Premier (PINC) 10-Q7 Feb 232023 Q2 Quarterly reportFinancial data

Company Profile

Cover

Cover - shares	6 Months Ended
Cover - shares	Dec. 31, 2022	Feb. 02, 2023
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Dec. 31, 2022
Document Transition Report	false
Entity File Number	001-36092
Entity Registrant Name	Premier, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	35-2477140
Entity Address, Address Line One	13034 Ballantyne Corporate Place
Entity Address, City or Town	Charlotte,
Entity Address, State or Province	NC
Entity Address, Postal Zip Code	28277
City Area Code	704
Local Phone Number	357-0022
Title of 12(b) Security	Class A Common Stock, $0.01 Par Value
Trading Symbol	PINC
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		118,867,338
Entity Central Index Key	0001577916
Current Fiscal Year End Date	--06-30
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q2
Amendment Flag	false

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2022	Jun. 30, 2022
Assets
Cash and cash equivalents	$ 94,623	$ 86,143
Accounts receivable (net of $1,932 and $2,043 allowance for credit losses, respectively)	120,917	114,129
Contract assets (net of $918 and $755 allowance for credit losses, respectively)	284,126	260,061
Inventory	116,421	119,652
Prepaid expenses and other current assets	57,878	65,581
Total current assets	673,965	645,566
Property and equipment (net of $622,358 and $578,644 accumulated depreciation, respectively)	207,045	213,379
Intangible assets (net of $241,132 and $217,582 accumulated amortization, respectively)	452,845	356,572
Goodwill	1,069,300	999,913
Deferred income tax assets	723,073	725,032
Deferred compensation plan assets	44,609	47,436
Investments in unconsolidated affiliates	217,110	215,545
Operating lease right-of-use assets	34,488	39,530
Other assets	116,959	114,154
Total assets	3,539,394	3,357,127
Liabilities and stockholders' equity
Accounts payable	61,422	44,631
Accrued expenses	49,351	40,968
Revenue share obligations	255,369	245,395
Accrued compensation and benefits	56,591	93,638
Deferred revenue	26,964	30,463
Current portion of notes payable to former limited partners	98,736	97,806
Line of credit and current portion of long-term debt	301,946	153,053
Other current liabilities	83,649	47,183
Total current liabilities	934,028	753,137
Long-term debt, less current portion	1,008	2,280
Notes payable to former limited partners, less current portion	151,588	201,188
Deferred compensation plan obligations	44,609	47,436
Deferred consideration, less current portion	29,026	28,702
Operating lease liabilities, less current portion	27,487	32,960
Other liabilities	45,575	42,574
Total liabilities	1,233,321	1,108,277
Commitments and contingencies (Note 13)
Stockholders' equity:
Class A common stock, $0.01 par value, 500,000,000 shares authorized; 125,295,961 shares issued and 118,866,586 shares outstanding at December 31, 2022 and 124,481,610 shares issued and 118,052,235 shares outstanding at June 30, 2022	1,253	1,245
Treasury stock, at cost; 6,429,375 shares at both December 31, 2022 and June 30, 2022	(250,129)	(250,129)
Additional paid-in capital	2,166,909	2,166,047
Retained earnings	388,052	331,690
Accumulated other comprehensive loss	(12)	(3)
Total stockholders' equity	2,306,073	2,248,850
Total liabilities and stockholders' equity	$ 3,539,394	$ 3,357,127

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Dec. 31, 2022	Jun. 30, 2022
Allowance for doubtful accounts	$ 1,932	$ 2,043
Allowance for credit losses	918	755
Accumulated depreciation	622,358	578,644
Accumulated amortization	$ 241,132	$ 217,582
Treasury stock, shares (in shares)	6,429,375	6,429,375
Class A Common Stock
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized (in shares)	500,000,000	500,000,000
Common stock, shares issued (in shares)	125,295,961	124,481,610
Common stock outstanding (in shares)	118,866,586	118,052,235

Condensed Consolidated Statemen

Condensed Consolidated Statements of Income and Comprehensive Income - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021
Net revenue:
Net revenue	$ 359,626	$ 379,215	$ 673,499	$ 744,362
Cost of revenue:
Cost of revenue	116,885	142,715	228,773	295,886
Gross profit	242,741	236,500	444,726	448,476
Operating expenses:
Selling, general and administrative	140,528	146,840	272,578	274,654
Research and development	1,000	846	1,975	1,840
Amortization of purchased intangible assets	13,047	10,850	23,499	21,739
Operating expenses	154,575	158,536	298,052	298,233
Operating income	88,166	77,964	146,674	150,243
Equity in net income of unconsolidated affiliates	1,674	6,116	9,917	13,174
Interest expense, net	(4,631)	(2,873)	(7,490)	(5,661)
Gain on FFF Put and Call Rights	0	0	0	64,110
Other income, net	2,930	2,392	766	2,072
Other (expense) income, net	(27)	5,635	3,193	73,695
Income before income taxes	88,139	83,599	149,867	223,938
Income tax expense	23,765	6,367	42,534	25,400
Net income	64,374	77,232	107,333	198,538
Net income attributable to non-controlling interest	(328)	(1,687)	(571)	(989)
Net income attributable to stockholders	64,046	75,545	106,762	197,549
Comprehensive income:
Net income	64,374	77,232	107,333	198,538
Comprehensive income attributable to non-controlling interest	(328)	(1,687)	(571)	(989)
Foreign currency translation gain (loss)	1	(1)	(9)	(1)
Comprehensive income attributable to stockholders	$ 64,047	$ 75,544	$ 106,753	$ 197,548
Weighted average shares outstanding:
Basic (in shares)	118,787	121,181	118,569	122,063
Diluted (in shares)	119,652	122,473	119,842	123,523
Earnings per share attributable to stockholders:
Basic (in dollars per share)	$ 0.54	$ 0.62	$ 0.90	$ 1.62
Diluted (in dollars per share)	$ 0.54	$ 0.62	$ 0.89	$ 1.61
Services and software licenses
Net revenue:
Net revenue	$ 292,633	$ 267,449	$ 547,645	$ 514,166
Cost of revenue:
Cost of revenue	55,265	45,782	109,279	89,591
Net administrative fees
Net revenue:
Net revenue	154,423	150,403	304,429	299,865
Software licenses, other services and support
Net revenue:
Net revenue	138,210	117,046	243,216	214,301
Products
Net revenue:
Net revenue	66,993	111,766	125,854	230,196
Cost of revenue:
Cost of revenue	$ 61,620	$ 96,933	$ 119,494	$ 206,295

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Class A Common Stock	Common Stock Class A Common Stock	Treasury Stock	Additional Paid-In Capital	Retained Earnings	Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Jun. 30, 2021			122,533,000
Beginning balance at Jun. 30, 2021	$ 2,229,893		$ 1,225	$ 0	$ 2,059,194	$ 169,474	$ 0
Treasury stock, beginning balance (in shares) at Jun. 30, 2021				0
Increase (Decrease) in Stockholders' Equity
Issuance of Class A common stock under equity incentive plan (in shares)			1,239,000
Issuance of Class A common stock under equity incentive plan	22,864		$ 13		22,851
Treasury stock (in shares)			1,091,000	1,091,000
Treasury stock	(42,628)			$ (42,628)
Stock-based compensation expense	7,554				7,554
Repurchase of vested restricted units for employee tax-withholding	(9,171)				(9,171)
Net income	121,306					121,306
Net income attributable to non-controlling interest	0				(698)	698
Dividends	(24,877)					(24,877)
Non-controlling interest related to acquisition	23,145				23,145
Treasury stock, ending balance (in shares) at Sep. 30, 2021				1,091,000
Ending balance (in shares) at Sep. 30, 2021			122,681,000
Ending balance at Sep. 30, 2021	2,328,086		$ 1,238	$ (42,628)	2,102,875	266,601	0
Beginning balance (in shares) at Jun. 30, 2021			122,533,000
Beginning balance at Jun. 30, 2021	2,229,893		$ 1,225	$ 0	2,059,194	169,474	0
Treasury stock, beginning balance (in shares) at Jun. 30, 2021				0
Increase (Decrease) in Stockholders' Equity
Net income	198,538
Treasury stock, ending balance (in shares) at Dec. 31, 2021				4,468,000
Ending balance (in shares) at Dec. 31, 2021			119,935,000
Ending balance at Dec. 31, 2021	2,278,802		$ 1,244	$ (176,024)	2,135,687	317,896	(1)
Beginning balance (in shares) at Sep. 30, 2021			122,681,000
Beginning balance at Sep. 30, 2021	2,328,086		$ 1,238	$ (42,628)	2,102,875	266,601	0
Treasury stock, beginning balance (in shares) at Sep. 30, 2021				1,091,000
Increase (Decrease) in Stockholders' Equity
Issuance of Class A common stock under equity incentive plan (in shares)			579,000
Issuance of Class A common stock under equity incentive plan	14,403		$ 5		14,398
Issuance of Class A common stock under employee stock purchase plan (in shares)			52,000
Issuance of Class A common stock under employee stock purchase plan	1,977		$ 1		1,976
Treasury stock (in shares)			3,377,000	3,377,000
Treasury stock	(133,396)			$ (133,396)
Stock-based compensation expense	16,234				16,234
Repurchase of vested restricted units for employee tax-withholding	(1,495)				(1,495)
Net income	77,232					77,232
Net income attributable to non-controlling interest	0				1,687	(1,687)
Change in ownership of consolidated entity	12				12
Dividends	(24,250)					(24,250)
Foreign currency translation adjustment	(1)						(1)
Treasury stock, ending balance (in shares) at Dec. 31, 2021				4,468,000
Ending balance (in shares) at Dec. 31, 2021			119,935,000
Ending balance at Dec. 31, 2021	2,278,802		$ 1,244	$ (176,024)	2,135,687	317,896	(1)
Beginning balance (in shares) at Jun. 30, 2022		118,052,235	118,052,000
Beginning balance at Jun. 30, 2022	2,248,850		$ 1,245	$ (250,129)	2,166,047	331,690	(3)
Treasury stock, beginning balance (in shares) at Jun. 30, 2022				6,429,000
Increase (Decrease) in Stockholders' Equity
Issuance of Class A common stock under equity incentive plan (in shares)			694,000
Issuance of Class A common stock under equity incentive plan	644		$ 7		637
Stock-based compensation expense	7,136				7,136
Repurchase of vested restricted units for employee tax-withholding	(13,089)				(13,089)
Net income	42,959					42,959
Net income attributable to non-controlling interest	0				243	(243)
Change in ownership of consolidated entity	26				26
Dividends	(25,097)					(25,097)
Foreign currency translation adjustment	(10)						(10)
Treasury stock, ending balance (in shares) at Sep. 30, 2022				6,429,000
Ending balance (in shares) at Sep. 30, 2022			118,746,000
Ending balance at Sep. 30, 2022	2,261,419		$ 1,252	$ (250,129)	2,161,000	349,309	(13)
Beginning balance (in shares) at Jun. 30, 2022		118,052,235	118,052,000
Beginning balance at Jun. 30, 2022	2,248,850		$ 1,245	$ (250,129)	2,166,047	331,690	(3)
Treasury stock, beginning balance (in shares) at Jun. 30, 2022				6,429,000
Increase (Decrease) in Stockholders' Equity
Net income	107,333
Other	590				590
Treasury stock, ending balance (in shares) at Dec. 31, 2022				6,429,000
Ending balance (in shares) at Dec. 31, 2022		118,866,586	118,867,000
Ending balance at Dec. 31, 2022	2,306,073		$ 1,253	$ (250,129)	2,166,909	388,052	(12)
Beginning balance (in shares) at Sep. 30, 2022			118,746,000
Beginning balance at Sep. 30, 2022	2,261,419		$ 1,252	$ (250,129)	2,161,000	349,309	(13)
Treasury stock, beginning balance (in shares) at Sep. 30, 2022				6,429,000
Increase (Decrease) in Stockholders' Equity
Issuance of Class A common stock under equity incentive plan (in shares)			54,000
Issuance of Class A common stock under equity incentive plan	60		$ 0		60
Issuance of Class A common stock under employee stock purchase plan (in shares)			67,000
Issuance of Class A common stock under employee stock purchase plan	2,268		$ 1		2,267
Stock-based compensation expense	2,679				2,679
Repurchase of vested restricted units for employee tax-withholding	(41)				(41)
Net income	64,374					64,374
Net income attributable to non-controlling interest	0				328	(328)
Change in ownership of consolidated entity	26				26
Dividends	(25,303)					(25,303)
Foreign currency translation adjustment	1					0	1
Treasury stock, ending balance (in shares) at Dec. 31, 2022				6,429,000
Ending balance (in shares) at Dec. 31, 2022		118,866,586	118,867,000
Ending balance at Dec. 31, 2022	$ 2,306,073		$ 1,253	$ (250,129)	$ 2,166,909	$ 388,052	$ (12)

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021
Operating activities
Net income	$ 64,374	$ 77,232	$ 107,333	$ 198,538
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	34,486	31,720	68,377	63,205
Equity in net income of unconsolidated affiliates	(1,674)	(6,116)	(9,917)	(13,174)
Deferred income taxes			1,959	19,890
Stock-based compensation			9,815	23,788
Gain on FFF Put and Call Rights	0	0	0	(64,110)
Other			10,167	930
Changes in operating assets and liabilities, net of the effects of acquisitions:
Accounts receivable, inventories, prepaid expenses and other assets			15,771	50,164
Contract assets			(26,458)	(22,963)
Accounts payable, accrued expenses, deferred revenue, revenue share obligations and other liabilities			19,678	(58,741)
Net cash provided by operating activities			196,725	197,527
Investing activities
Purchases of property and equipment	(19,486)	(21,610)	(38,416)	(42,660)
Acquisition of businesses and equity method investments, net of cash acquired			(187,750)	(26,000)
Other			(1,300)	0
Net cash used in investing activities			(227,466)	(68,660)
Financing activities
Payments made on notes payable			(51,049)	(50,621)
Proceeds from credit facility			285,000	175,000
Payments on credit facility			(135,000)	(125,000)
Proceeds from exercise of stock options under equity incentive plan			704	37,267
Cash dividends paid			(50,205)	(49,044)
Repurchase of Class A common stock (held as treasury stock)			0	(173,916)
Other			(10,220)	14,468
Net cash provided by (used in) financing activities			39,230	(171,846)
Effect of exchange rate changes on cash flows			(9)	(1)
Net increase (decrease) in cash and cash equivalents			8,480	(42,980)
Cash and cash equivalents at beginning of period			86,143	129,141
Cash and cash equivalents at end of period	$ 94,623	$ 86,161	$ 94,623	$ 86,161

ORGANIZATION

ORGANIZATION	6 Months Ended
ORGANIZATION	Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
ORGANIZATION	(1) ORGANIZATION Organization Premier, Inc. (“Premier” or the “Company”) is a publicly held, for-profit Delaware corporation located in the United States. The Company is a holding company with no material business operations of its own. The Company’s primary asset is its equity interest in its wholly owned subsidiary Premier Healthcare Solutions, Inc., a Delaware corporation (“PHSI”). The Company conducts substantially all of its business operations through PHSI and its other consolidated subsidiaries. The Company, together with its subsidiaries and affiliates, is a leading healthcare performance improvement company that unites hospitals, health systems, physicians, employers, product suppliers, service providers, and other healthcare providers and organizations to improve and innovate in the clinical, financial and operational areas of their businesses to meet the demands of a rapidly evolving healthcare industry and continues to expand its capabilities to more fully address and coordinate care improvement and standardization in the employer, payor and life sciences markets. The Company also provides services to other businesses, including food service, schools and universities. The Company’s business model and solutions are designed to provide its members and other customers access to scale efficiencies, spread the cost of their development, provide actionable intelligence derived from anonymized data in the Company’s enterprise data warehouse, mitigate the risk of innovation and disseminate best practices to help the Company’s members and other customers succeed in their transformation to higher quality and more cost-effective healthcare. The Company, together with its subsidiaries and affiliates, delivers its integrated platform of solutions through two business segments: Supply Chain Services and Performance Services. See Note 14 - Segments for further information related to the Company’s reportable business segments. The Supply Chain Services segment includes one of the largest healthcare group purchasing organization (“GPO”) programs in the United States, supply chain co-management, purchased services and direct sourcing activities. The Performance Services segment consists of three sub-brands: PINC AI TM , the Company’s technology and services platform with offerings that help optimize performance in three main areas – clinical intelligence, margin improvement and value-based care – using advanced analytics to identify improvement opportunities, consulting and managed services for clinical and operational design, and workflow solutions to hardwire sustainable change in the provider, life sciences and payer markets; Contigo Health ® , the Company’s direct-to-employer business which provides third-party administrator services and management of health-benefit programs that allow employers to contract directly with healthcare providers as well as partner with healthcare providers to provide employers access to a specialized care network through Contigo Health’s centers of excellence program and cost containment and wrap network; and Remitra TM , the Company’s digital invoicing and payables business which provides financial support services to healthcare providers and suppliers. Principles of Consolidation The accompanying condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the SEC and in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and include the assets, liabilities, revenues and expenses of all majority-owned subsidiaries over which the Company exercised control and when applicable, entities for which the Company had a controlling financial interest or was the primary beneficiary. All intercompany transactions have been eliminated upon consolidation. Accordingly, certain information and disclosures normally included in annual financial statements have been condensed or omitted. The accompanying condensed consolidated financial statements reflect all adjustments that, in the opinion of management, are necessary for a fair presentation of results of operations and financial condition for the interim periods shown, consisting of normal recurring adjustments, unless otherwise disclosed. The Company believes that the disclosures are adequate to make the information presented not misleading and should be read in conjunction with the audited consolidated financial statements and related footnotes contained in the 2022 Annual Report. Supplementary Cash Flows Information The following table presents supplementary cash flows information for the six months ended December 31, 2022 and 2021 (in thousands): Six Months Ended December 31, 2022 2021 Supplemental schedule of non-cash investing and financing activities: Increase in treasury stock related to a payable as a result of applying trade date accounting when recording the repurchase of Class A common stock $ — $ 2,108 Non-cash additions to property and equipment 84 8 Accrued dividend equivalents 519 244 Use of Estimates in the Preparation of Financial Statements

SIGNIFICANT ACCOUNTING POLICIES

SIGNIFICANT ACCOUNTING POLICIES	6 Months Ended
SIGNIFICANT ACCOUNTING POLICIES	Dec. 31, 2022
Accounting Policies [Abstract]
SIGNIFICANT ACCOUNTING POLICIES	(2) SIGNIFICANT ACCOUNTING POLICIES There have been no material changes to the Company’s significant accounting policies as described in the 2022 Annual Report. Recently Adopted Accounting Standards In October 2021, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2021-08 Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers, (“ASU 2021-08”), which requires that an acquirer recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with Topic 606, Revenue from Contracts with Customers. The Company adopted ASU 2021-08 during the second quarter of fiscal 2023. The standard did not have a material impact on the Company’s financial statements nor its related disclosures.

BUSINESS ACQUISITIONS

BUSINESS ACQUISITIONS	6 Months Ended
BUSINESS ACQUISITIONS	Dec. 31, 2022
Business Combination and Asset Acquisition [Abstract]
BUSINESS ACQUISITIONS	(3) BUSINESS ACQUISITIONS Acquisition of TRPN Direct Pay, Inc. and Devon Health, Inc. Assets On October 13, 2022, the Company, through its consolidated subsidiary Contigo Health, LLC (“Contigo Health”), acquired certain assets (the “TRPN Transferred Assets”) of TRPN Direct Pay, Inc. and Devon Health, Inc. (collectively, “TRPN”), including contracts with more than 900,000 providers (collectively, the “Assumed Contracts”), and agreed to assume certain liabilities and obligations of TRPN with regard to the Assumed Contracts (referred to as the “TRPN acquisition”). The TRPN Transferred Assets relate to businesses of TRPN focused on improving access to quality healthcare and reducing the cost of medical claims through pre-negotiated discounts with network providers, including acute-care hospitals, surgery centers, physicians, and other non-acute providers in the United States. Contigo Health also agreed to license proprietary cost containment technology of TRPN. The purchase price paid by the Company to complete the TRPN acquisition consisted of cash of $177.5 million, funded with borrowings under the Company’s Credit Facility (as defined in Note 8 - Debt and Notes Payable) and cash on hand, of which $17.8 million was placed in escrow to satisfy indemnification obligations of TRPN to Contigo Health and its affiliates and other parties related thereto under the purchase agreement governing the TRPN acquisition (“TRPN Purchase Agreement”). The Company has accounted for the TRPN acquisition as a business combination whereby the purchase price was allocated to tangible and intangible assets acquired and liabilities assumed based on their fair values. The total fair value assigned to intangible assets acquired was $116.6 million, consisting primarily of the provider network. The TRPN acquisition resulted in the recognition of $60.9 million of goodwill attributable to the anticipated profitability of TRPN, based on the purchase price paid in the acquisition compared to the fair value of the net assets acquired. The TRPN acquisition was considered an asset acquisition for income tax purposes. Accordingly, the Company expects tax goodwill to be deductible for tax purposes. The initial purchase price allocation for the TRPN acquisition is preliminary and subject to changes in the valuation of the assets acquired and liabilities assumed. TRPN is being integrated within Premier under Contigo Health and is reported as part of the Performance Services Segment. Pro forma results of operations for the acquisition have not been presented because the effects on revenue and net income were not material to the Company’s historical consolidated financial statements.

INVESTMENTS

INVESTMENTS	6 Months Ended
INVESTMENTS	Dec. 31, 2022
Equity Method Investments and Joint Ventures [Abstract]
INVESTMENTS	(4) INVESTMENTS Investments in Unconsolidated Affiliates The Company’s investments in unconsolidated affiliates consisted of the following (in thousands): Equity in Net Income Three Months Ended Six Months Ended Carrying Value December 31, December 31, December 31, 2022 June 30, 2022 2022 2021 2022 2021 FFF $ 135,214 $ 137,162 $ 518 $ 3,454 $ 7,705 $ 9,399 Exela 28,503 27,733 632 1,003 770 1,003 Qventus 16,000 16,000 — — — — Prestige 16,068 15,597 291 1,579 471 2,337 Other investments 21,325 19,053 233 80 971 435 Total investments $ 217,110 $ 215,545 $ 1,674 $ 6,116 $ 9,917 $ 13,174 The Company, through its indirect, wholly owned subsidiary Premier Supply Chain Improvement, Inc. (“PSCI”), held a 49% interest in FFF Enterprises, Inc. (“FFF”) through its ownership of stock of FFF at December 31, 2022 and June 30, 2022. The Company, through its consolidated subsidiary, ExPre Holdings, LLC (“ExPre”), held an approximate 6% interest in Exela Holdings, Inc. (“Exela”) through its ownership of Exela Class A common stock at December 31, 2022. At December 31, 2022, the Company owned approximately 15% of the membership interest of ExPre, with the remainder of the membership interests held by 11 member health systems or their affiliates. The Company, through its consolidated subsidiary, PRAM Holdings, LLC (“PRAM”), held an approximate 20% interest in Prestige Ameritech Ltd. (“Prestige”) through its ownership of Prestige limited partnership units at December 31, 2022. At December 31, 2022, the Company owned approximately 26% of the membership interest of PRAM, with the remainder of the membership interests held by 16 member health systems or their affiliates. The Company accounts for its investments in FFF, Exela and Prestige using the equity method of accounting and includes each investment as part of the Supply Chain Services segment.

FAIR VALUE MEASUREMENTS

FAIR VALUE MEASUREMENTS	6 Months Ended
FAIR VALUE MEASUREMENTS	Dec. 31, 2022
Fair Value Disclosures [Abstract]
FAIR VALUE MEASUREMENTS	(5) FAIR VALUE MEASUREMENTS Recurring Fair Value Measurements The following table represents the Company’s financial assets and liabilities, which are measured at fair value on a recurring basis (in thousands): Fair Value of Financial Assets and Liabilities Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs December 31, 2022 Cash equivalents $ 76 $ 76 $ — $ — Deferred compensation plan assets 49,475 49,475 — — Total assets 49,551 49,551 — — Earn-out liabilities 24,098 — — 24,098 Total liabilities $ 24,098 $ — $ — $ 24,098 June 30, 2022 Cash equivalents $ 75 $ 75 $ — $ — Deferred compensation plan assets 52,718 52,718 — — Total assets 52,793 52,793 — — Earn-out liabilities 22,789 — — 22,789 Total liabilities $ 22,789 $ — $ — $ 22,789 Deferred compensation plan assets consisted of highly liquid mutual fund investments, which were classified as Level 1. The current portion of deferred compensation plan assets ($4.9 million and $5.3 million at December 31, 2022 and June 30, 2022, respectively) was included in prepaid expenses and other current assets in the accompanying Condensed Consolidated Balance Sheets. Financial Instruments Measured at Fair Value on a Recurring Basis Using Significant Unobservable Inputs (Level 3) FFF Put and Call Rights On July 29, 2021, the FFF shareholders’ agreement was amended resulting in the termination of the FFF Put Right and the derecognition of the FFF Put Right liability. In the event of a Key Man Event (generally defined in the FFF shareholders’ agreement as the resignation, termination for cause, death or disability of the majority shareholder), the Company has a call right that requires the majority shareholder to sell its remaining interest in FFF to the Company, and is exercisable at any time within 180 calendar days after the date of a Key Man Event (the “Call Right”, together with the FFF Put Right, the “Put and Call Rights”). As of December 31, 2022 and June 30, 2022, the Call Right had zero value. In the event that the Call Right is exercised, the purchase price for the additional interest in FFF will be at a per share price equal to FFF’s earnings before interest, taxes, depreciation and amortization (“FFF EBITDA”) over the twelve calendar months prior to the purchase date multiplied by a market adjusted multiple, adjusted for any outstanding debt and cash and cash equivalents, divided by the number of shares of FFF common stock then outstanding (“Equity Value per Share”). Earn-out liabilities An earn-out liability was established in connection with the acquisition of substantially all of the assets and certain liabilities of Acurity, Inc. and Nexera, Inc. (the “Acurity and Nexera asset acquisition”) in February 2020 based upon the Company’s achievement of a range of member renewals on terms to be agreed to by the Company and Greater New York Hospital Association based on prevailing market conditions in December 2023. The earn-out liability is classified as Level 3 of the fair value hierarchy. The earn-out liability arising from expected earn-out payments related to the Acurity and Nexera asset acquisition was measured on the acquisition date using a probability-weighted expected payment model and is remeasured periodically due to changes in management’s estimates of the number of transferred member renewals and market conditions. In determining the fair value of the contingent liabilities, management reviews the current results of the acquired business, along with projected results for the remaining earn-out period, to calculate the expected earn-out payment to be made based on the contractual terms set out in the acquisition agreement. The Acurity and Nexera earn-out liability utilized a credit spread of 1.4% at December 31, 2022 and 1.6% at June 30, 2022. As of December 31, 2022 and June 30, 2022, the undiscounted range of outcomes is between $0 and $30.0 million. A significant decrease in the probability could result in a significant decrease in the value of the earn-out liability. The fair value of the Acurity and Nexera earn-out liability at December 31, 2022 and June 30, 2022 was $22.6 million and $22.8 million, respectively. Acurity and Nexera Earn-out (a) Input assumptions As of December 31, 2022 As of June 30, 2022 Probability of transferred member renewal percentage < 50% 5.0 % 5.0 % Probability of transferred member renewal percentage between 50% and 65% 10.0 % 10.0 % Probability of transferred member renewal percentage between 65% and 80% 25.0 % 25.0 % Probability of transferred member renewal percentage > 80% 60.0 % 60.0 % Credit spread 1.4 % 1.6 % _________________________________ (a) The Acurity and Nexera earn-out liability was initially valued as of February 28, 2020. A reconciliation of the Company’s Put Right and earn-out liabilities is as follows (in thousands): Beginning Balance Purchases (Settlements) (a) (Gain)/Loss (b) Ending Balance Three Months Ended December 31, 2022 Earn-out liabilities $ 22,361 $ 1,460 $ 277 $ 24,098 Total Level 3 liabilities $ 22,361 $ 1,460 $ 277 $ 24,098 Three Months Ended December 31, 2021 Earn-out liabilities $ 24,368 $ — $ (229) $ 24,139 Total Level 3 liabilities $ 24,368 $ — $ (229) $ 24,139 Six Months Ended December 31, 2022 Earn-out liabilities $ 22,789 $ 1,460 $ (151) $ 24,098 Total Level 3 liabilities $ 22,789 $ 1,460 $ (151) $ 24,098 Six Months Ended December 31, 2021 Earn-out liabilities $ 24,249 $ — $ (110) $ 24,139 FFF put right 64,110 (64,110) — — Total Level 3 liabilities $ 88,359 $ (64,110) $ (110) $ 24,139 _________________________________ (a) Purchases for the three and six months ended December 31, 2022 includes an earn-out which has not been earned or paid as of December 31, 2022. Settlements for the six months ended December 31, 2021 includes non-cash gain recognized as a result the termination of the FFF Put Right and the derecognition of the FFF Put Right liability. (b) A gain on level 3 liability balances will decrease the liability ending balance whereas a loss on level 3 liability balance will increase the liability ending balance. Non-Recurring Fair Value Measurements As a result of the August 2020 Restructuring, the Company recorded non-interest bearing notes payable to former limited partners during the three months ended September 30, 2020. Although these notes are non-interest bearing, they include a Level 2 input associated with an implied fixed annual interest rate of 1.8% (see Note 8 - Debt and Notes Payable). As of December 31, 2022 and June 30, 2022, the notes payable to former limited partners were recorded net of discounts of $6.4 million and $9.1 million, respectively. During the six months ended December 31, 2022, no non-recurring fair value measurements were required relating to the measurement of goodwill and intangible assets for impairment. However, purchase price allocations required significant non- recurring Level 3 inputs. The preliminary fair values of the acquired intangible assets resulting from the TRPN acquisition were determined using the income approach (see Note 3 - Business Acquisitions). Financial Instruments For Which Fair Value Only is Disclosed The fair values of non-interest bearing notes payable, classified as Level 2, were equal to the carrying value at December 31, 2022 and $0.1 million less than the carrying value at June 30, 2022 based on an assumed market interest rate of 1.6%. Other Financial Instruments

CONTRACT BALANCES

CONTRACT BALANCES	6 Months Ended
CONTRACT BALANCES	Dec. 31, 2022
Revenue from Contract with Customer [Abstract]
CONTRACT BALANCES	(6) CONTRACT BALANCES Deferred Revenue Revenue recognized during the six months ended December 31, 2022 that was included in the opening balance of deferred revenue at June 30, 2022 was $23.3 million, which is a result of satisfying certain performance obligations. Performance Obligations A performance obligation is a contractual obligation to transfer a distinct good or service to a customer. A contract’s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. Contracts may have a single performance obligation as the agreement to transfer individual goods or services is not separately identifiable from other contractual obligations and, therefore, not distinct, while other contracts may have multiple performance obligations, most commonly due to the contract covering multiple phases or deliverable arrangements (licensing fees, SaaS subscription fees, maintenance and support fees, and professional fees for consulting services). Refer to the Company’s significant accounting policies in the 2022 Annual Report for discussion of revenue recognition on contracts with customers. The reduction to net revenue recognized during the three months ended December 31, 2022 from performance obligations that were satisfied or partially satisfied in prior periods was $0.4 million. The reduction was driven by a $0.8 million decrease associated with revised forecasts from underlying contracts that include variable consideration components as well as additional fluctuations due to input method contracts which occur in the normal course of business. This decrease was partially offset by an increase of $0.4 million in net administrative fees revenue related to under-forecasted cash receipts received in the current period. Net revenue of $2.5 million was recognized during the six months ended December 31, 2022 from performance obligations that were satisfied or partially satisfied in prior periods. The net revenue recognized was driven by an increase of $4.6 million in net administrative fees revenue related to under-forecasted cash receipts received in the current period partially offset by a reduction of $2.1 million associated with revised forecasts from underlying contracts that include variable consideration components as well as additional fluctuations due to input method contracts which occur in the normal course of business. Net revenue of $8.1 million and $3.7 million was recognized during the three and six months ended December 31, 2021, respectively, from certain performance obligations that were satisfied or partially satisfied in prior periods. The net revenue recognized was driven by an increase of $7.3 million and $3.1 million, respectively, in net administrative fees revenue related to under-forecasted cash receipts received in the current period. There was also an increase of $0.8 million and $0.6 million, respectively, associated with revised forecasts from underlying contracts that include variable consideration components as well as additional fluctuations due to input method contracts which occur in the normal course of business. Remaining performance obligations represent the portion of the transaction price that has not yet been satisfied or achieved. As of December 31, 2022, the aggregate amount of the transaction price allocated to remaining performance obligations was $700.6 million. The Company expects to recognize approximately 42% of the remaining performance obligations over the next 12 months and an additional 23% over the following 12 months, with the remainder recognized thereafter.

GOODWILL AND INTANGIBLE ASSETS

GOODWILL AND INTANGIBLE ASSETS	6 Months Ended
GOODWILL AND INTANGIBLE ASSETS	Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
GOODWILL AND INTANGIBLE ASSETS	(7) GOODWILL AND INTANGIBLE ASSETS Goodwill Goodwill consisted of the following (in thousands): Supply Chain Services Performance Services Total June 30, 2022 $ 388,502 $ 611,411 $ 999,913 Acquisition of businesses and assets — 69,387 69,387 December 31, 2022 $ 388,502 $ 680,798 $ 1,069,300 Goodwill increased primarily due to the TRPN acquisition (see Note 3 - Business Acquisitions). The initial purchase price allocation for the TRPN acquisition is preliminary and subject to change in the valuation of the assets acquired and the liabilities assumed. Intangible Assets, Net Intangible assets, net consisted of the following (in thousands): Useful Life December 31, 2022 June 30, 2022 Member relationships 14.7 years $ 386,100 $ 386,100 Provider network 15.0 years 106,500 — Technology 7.1 years 99,317 98,017 Customer relationships 9.4 years 58,030 47,830 Non-compete agreements 5.2 years 17,715 17,315 Trade names 6.8 years 17,410 17,210 Other (a) 9.5 years 8,905 7,682 Total intangible assets 693,977 574,154 Accumulated amortization (241,132) (217,582) Total intangible assets, net $ 452,845 $ 356,572 _________________________________ (a) Includes a $1.0 million indefinite-lived asset. The net carrying value of intangible assets by segment was as follows (in thousands): December 31, 2022 June 30, 2022 Supply Chain Services $ 285,571 $ 301,611 Performance Services (a) 167,274 54,961 Total intangible assets, net $ 452,845 $ 356,572 _________________________________ (a) Includes a $1.0 million indefinite-lived asset. Total intangible assets increased primarily due to the TRPN acquisition (see Note 3 - Business Acquisitions). As part of the TRPN acquisition, the total fair value assigned to intangible assets acquired was $116.6 million, consisting primarily of the provider network of $106.5 million. The weighted average useful life of the acquired intangible assets is 14.1 years, with the provider network having a useful life of 15.0 years. Intangible asset amortization was $13.0 million and $10.9 million for the three months ended December 31, 2022 and 2021, respectively, and $23.5 million and $21.7 million for the six months ended December 31, 2022 and 2021, respectively. The estimated amortization expense for each of the next five fiscal years and thereafter is as follows (in thousands): 2023 (a) $ 24,407 2024 49,414 2025 47,788 2026 46,544 2027 43,893 Thereafter 239,799 Total amortization expense $ 451,845 (a) As of December 31, 2022, estimated amortization expense is for the period from January 1, 2023 to June 30, 2023.

DEBT AND NOTES PAYABLE

DEBT AND NOTES PAYABLE	6 Months Ended
DEBT AND NOTES PAYABLE	Dec. 31, 2022
Debt Disclosure [Abstract]
DEBT AND NOTES PAYABLE	(8) DEBT AND NOTES PAYABLE Long-term debt and notes payable consisted of the following (in thousands): December 31, 2022 June 30, 2022 Credit facility $ 300,000 $ 150,000 Notes payable to members, net of discount 250,324 298,994 Other notes payable 2,954 5,333 Total debt and notes payable 553,278 454,327 Less: current portion (400,682) (250,859) Total long-term debt and notes payable $ 152,596 $ 203,468 Credit Facility PHSI, along with its consolidated subsidiaries, Premier LP and PSCI, as Co-Borrowers, and certain domestic subsidiaries of the Co-Borrowers, as guarantors, entered into an unsecured Credit Facility, dated as of December 12, 2022 (the “Credit Facility”). The Credit Facility has a maturity date of December 12, 2027, subject to up to two one-year extensions at the request of the Co-Borrowers and approval of a majority of the lenders under the Credit Facility. The Credit Facility provides for borrowings of up to $1.0 billion with (i) a $50.0 million sub-facility for standby letters of credit and (ii) a $100.0 million sub-facility for swingline loans. The Credit Facility also provides that Co-Borrowers may from time to time (i) incur incremental term loans and (ii) request an increase in the revolving commitments under the Credit Facility, together up to an aggregate of $350.0 million, subject to the approval of the lenders providing such term loans or revolving commitment increase. The Credit Facility contains an unconditional and irrevocable guaranty of all obligations of Co-Borrowers under the Credit Facility by the current and future Guarantors. Premier is not a guarantor under the Credit Facility. The Credit Facility refinanced the Credit Facility dated November 9, 2018, as amended (the “Prior Loan Agreement”), and the Prior Loan Agreement, which was scheduled to mature on November 9, 2023, was terminated on December 12, 2022. The Prior Loan Agreement included a $1.0 billion unsecured revolving credit facility. At the time of its termination, outstanding borrowings, accrued interest and fees and expenses under the Prior Loan Agreement totaled $331.3 million, which was repaid with cash on hand and borrowings under the new Credit Facility. At the Company’s option, committed loans under the Credit Facility may be in the form of secured overnight financing rate loans (“SOFR Loans”) or base rate loans. SOFR Loans bear interest at SOFR plus an adjustment of 0.100% (“Adjusted Term SOFR”) plus the Applicable Rate (defined as a margin based on the Consolidated Total Net Leverage Ratio (as defined in the Credit Facility)). Base rate loans bear interest at the Base Rate (defined as the highest of the prime rate announced by the administrative agent, the federal funds effective rate plus 0.500%, the one-month Adjusted Term SOFR plus 1.000%, and 0.000%), plus the Applicable Rate. The Applicable Rate ranges from 1.250% to 1.750% for SOFR Loans and 0.250% to 0.750% for base rate loans. At December 31, 2022 , the interest rate for SOFR Loans was 5.708% and the interest rate for base rate loans was 7.750%. Co-Borrowers are required to pay a commitment fee ranging from 0.125% to 0.225% per annum on the actual daily unused amount of commitments under the Credit Facility. At December 31, 2022, the weighted average interest rate on outstanding borrowings under the Credit Facility was 5.633% and the annual commitment fee, based on the actual daily unused amount of commitments under the Credit Facility, was 0.125%. The Credit Facility contains customary representations and warranties as well as customary affirmative and negative covenants, including, among others, limitations on liens, indebtedness, fundamental changes, dispositions, restricted payments and investments. The Company was in compliance with all such covenants at December 31, 2022. The Credit Facility also contains customary events of default, including a cross-default of any indebtedness or guarantees in excess of $75.0 million. If any event of default occurs and is continuing, the administrative agent under the Credit Facility may, with the consent, or shall, at the request of a majority of the lenders under the Credit Facility, terminate the commitments and declare all of the amounts owed under the Credit Facility to be immediately due and payable. The Company had $300.0 million in outstanding borrowings under the Credit Facility at December 31, 2022 with $699.9 million of available borrowing capacity after reductions for outstanding borrowings and outstanding letters of credit. For the six months ended December 31, 2022, the Company borrowed $285.0 million and repaid $135.0 million of outstanding borrowings under the Prior Loan Agreement. For the six months ended December 31, 2022, there were no borrowings or repayments under the Credit Facility. In January 2023, the Company repaid $30.0 million of outstanding borrowings under the Credit Facility. Notes Payable Notes Payable to Former Limited Partners At December 31, 2022, the Company had $250.3 million of notes payable to former LPs, net of discounts on notes payable of $6.4 million, of which $98.7 million was recorded to current portion of notes payable to former limited partners in the accompanying Condensed Consolidated Balance Sheets. At June 30, 2022, the Company had $299.0 million of notes payable to former LPs, net of discounts on notes payable of $9.1 million, of which $97.8 million was recorded to current portion of notes payable to former limited partners in the accompanying Condensed Consolidated Balance Sheets. The notes payable to former LPs were issued in connection with the early termination of the TRA as part of the August 2020 Restructuring. Although the notes payable to former LPs are non-interest bearing, pursuant to GAAP requirements, they were recorded net of imputed interest at a fixed annual rate of 1.8%. Other At December 31, 2022 and June 30, 2022, the Company had $3.0 million and $5.3 million in other notes payable, respectively, of which $1.9 million and $3.1 million, respectively, were included in current portion of long-term debt in the accompanying Condensed Consolidated Balance Sheets. Other notes payable do not bear interest and generally have stated maturities of three

STOCKHOLDERS' EQUITY

STOCKHOLDERS' EQUITY	6 Months Ended
STOCKHOLDERS' EQUITY	Dec. 31, 2022
Equity [Abstract]
STOCKHOLDERS' EQUITY	(9) STOCKHOLDERS' EQUITY As of December 31, 2022, there were 118,866,586 shares of the Company’s Class A common stock, par value $0.01 per share, outstanding. During the six months ended December 31, 2022, the Company paid cash dividends of $0.21 per share on outstanding shares of Class A common stock to stockholders on each of September 15, 2022 and December 15, 2022. On January 26, 2023, the Board of Directors declared a quarterly cash dividend of $0.21 per share, payable on March 15, 2023 to stockholders of record on March 1, 2023.

EARNINGS PER SHARE

EARNINGS PER SHARE	6 Months Ended
EARNINGS PER SHARE	Dec. 31, 2022
Earnings Per Share [Abstract]
EARNINGS PER SHARE	(10) EARNINGS PER SHARE Basic earnings per share is computed by dividing net income attributable to stockholders by the weighted average number of shares of common stock outstanding for the period. Except when the effect would be anti-dilutive, the diluted earnings per share calculation, which is calculated using the treasury stock method, includes the impact of all potentially issuable dilutive shares of Class A common stock. The following table provides a reconciliation of the numerator and denominator used for basic and diluted earnings per share (in thousands, except per share amounts): Three Months Ended December 31, Six Months Ended December 31, 2022 2021 2022 2021 Numerator for basic earnings per share: Net income attributable to stockholders (a) $ 64,046 $ 75,545 $ 106,762 $ 197,549 Numerator for diluted earnings per share: Net income attributable to stockholders (a) $ 64,046 $ 75,545 $ 106,762 $ 197,549 Net loss attributable to non-controlling interest — — — 989 Net income for diluted earnings per share $ 64,046 $ 75,545 $ 106,762 $ 198,538 Three Months Ended December 31, Six Months Ended December 31, 2022 2021 2022 2021 Denominator for earnings per share: Basic weighted average shares outstanding (b) 118,787 121,181 118,569 122,063 Effect of dilutive securities: (c) Stock options 86 267 116 288 Restricted stock 466 540 514 516 Performance share awards 313 485 643 656 Diluted weighted average shares and assumed conversions 119,652 122,473 119,842 123,523 Earnings per share attributable to stockholders: Basic $ 0.54 $ 0.62 $ 0.90 $ 1.62 Diluted $ 0.54 $ 0.62 $ 0.89 $ 1.61 _________________________________ (a) Net income attributable to stockholders was calculated as follows (in thousands): Three Months Ended December 31, Six Months Ended December 31, 2022 2021 2022 2021 Net income $ 64,374 $ 77,232 $ 107,333 $ 198,538 Net income attributable to non-controlling interest (328) (1,687) (571) (989) Net income attributable to stockholders $ 64,046 $ 75,545 $ 106,762 $ 197,549 (b) Weighted average number of common shares used for basic earnings per share excludes the impact of all potentially issuable dilutive shares of Class A common stock for the three and six months ended December 31, 2022 and 2021. (c) For the three and six months ended December 31, 2022, the effect of 0.5 million and 0.7 million stock options and restricted stock units, respectively, was excluded from diluted weighted average shares outstanding as it had an anti-dilutive effect. Additionally, for the three and six months ended December 31, 2022, the effect of 0.2 million and 0.3 million performance share awards, respectively, was excluded from diluted weighted average shares outstanding as the awards had not satisfied the applicable performance criteria at the end of the period. For the six months ended December 31, 2021, the effect of 0.3 million stock options and restricted stock units was excluded from diluted weighted average shares outstanding as it had an anti-dilutive effect. Additionally, for the three and six months ended December 31, 2021 the effect of 0.2 million and 0.4 million performance share awards, respectively, was excluded from diluted weighted average shares outstanding as the awards had not satisfied the applicable performance criteria at the end of the period.

STOCK-BASED COMPENSATION

STOCK-BASED COMPENSATION	6 Months Ended
STOCK-BASED COMPENSATION	Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]
STOCK-BASED COMPENSATION	(11) STOCK-BASED COMPENSATION Stock-based compensation expense is recognized over the requisite service period, which generally equals the stated vesting period. The associated deferred tax benefit was calculated at a tax rate of 26% for the six months ended December 31, 2022 and 2021, which represents the expected effective income tax rate at the time of the compensation expense deduction and differs from the Company’s current effective income tax rate. See Note 12 - Income Taxes for further information. Stock-based compensation expense and the resulting deferred tax benefits were as follows (in thousands): Three Months Ended December 31, Six Months Ended December 31, 2022 2021 2022 2021 Pre-tax stock-based compensation expense $ 2,679 $ 16,234 $ 9,815 $ 23,788 Less: deferred tax benefit (a) 1,060 3,650 2,007 4,725 Total stock-based compensation expense, net of tax $ 1,619 $ 12,584 $ 7,808 $ 19,063 _________________________________ (a) For the three and six months ended December 31, 2022, the deferred tax benefit was increased by $0.4 million and reduced by $0.5 million, respectively, attributable to stock-based compensation expense that is nondeductible for tax purposes pursuant to Section 162(m) as amended by the Tax Cuts and Jobs Act of 2017. Premier 2013 Equity Incentive Plan The Premier 2013 Equity Incentive Plan, as amended and restated (and including any further amendments thereto, the “2013 Equity Incentive Plan”) provides for grants of up to 14.8 million shares of Class A common stock, all of which are eligible to be issued as non-qualified stock options, incentive stock options, stock appreciation rights, restricted stock, restricted stock units or performance share awards. As of December 31, 2022, there were 3.9 million shares available for grant under the 2013 Equity Incentive Plan. The following table includes information related to restricted stock, performance share awards and stock options for the six months ended December 31, 2022: Restricted Stock Performance Share Awards Stock Options Number of Awards Weighted Average Fair Value at Grant Date Number of Awards Weighted Average Fair Value at Grant Date Number of Options Weighted Average Exercise Price Outstanding at June 30, 2022 1,201,130 $ 35.59 1,578,795 $ 33.66 896,354 $ 30.38 Granted 408,420 36.78 823,009 35.34 — — Vested/exercised (234,842) 36.73 (826,743) 36.35 (24,351) 32.84 Forfeited (50,326) 35.61 (53,538) 32.97 (2,260) 35.65 Outstanding at December 31, 2022 1,324,382 $ 35.75 1,521,523 $ 33.11 869,743 $ 30.30 Stock options outstanding and exercisable at December 31, 2022 869,743 $ 30.30 Restricted stock units and restricted stock awards issued and outstanding generally vest over a three-year period for employees and a one-year period for directors. Performance share awards issued and outstanding generally vest over a three-year period if performance targets are met. Stock options generally vest in equal annual installments over three years. Stock options have a term of ten years from the date of grant. Vested stock options will generally expire either twelve months after an employee’s termination with the Company or 90 days after an employee’s termination with the Company, depending on the termination circumstances. Unrecognized stock-based compensation expense at December 31, 2022 was as follows (in thousands). At December 31, 2022, there was no unrecognized stock-based compensation expense for outstanding stock options. Unrecognized Stock-Based Compensation Expense Weighted Average Amortization Period Restricted stock $ 27,707 2.0 years Performance share awards 27,743 2.0 years Total unrecognized stock-based compensation expense $ 55,450 2.0 years The aggregate intrinsic value of stock options at December 31, 2022 was as follows (in thousands): Intrinsic Value of Stock Options Outstanding and exercisable $ 4,178 Exercised during the six months ended December 31, 2022 78

INCOME TAXES

INCOME TAXES	6 Months Ended
INCOME TAXES	Dec. 31, 2022
Income Tax Disclosure [Abstract]
INCOME TAXES	(12) INCOME TAXES Income tax expense for the three months ended December 31, 2022 and 2021 was $23.8 million and $6.4 million, respectively, which reflects effective tax rates of 27% and 8%, respectively. The change in the effective tax rate for the three months ended December 31, 2022 is primarily driven by the prior year valuation allowance release resulting from the Subsidiary Reorganization. Excluding the valuation allowance release, the effective tax rate would have been 19% for the three months ended December 31, 2021 with the remaining difference primarily related to repricing due to the Subsidiary Reorganization and state legislative changes.

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	6 Months Ended
COMMITMENTS AND CONTINGENCIES	Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	(13) COMMITMENTS AND CONTINGENCIES Operating Leases Operating lease expense for both the three months ended December 31, 2022 and 2021 was $2.5 million. Operating lease expense for the six months ended December 31, 2022 and 2021 was $5.0 million and $5.1 million, respectively. As of December 31, 2022, the weighted average remaining lease term was 3.3 years and the weighted average discount rate was 4%. Future minimum lease payments under noncancellable operating leases with initial lease terms in excess of one year were as follows (in thousands): December 31, 2022 June 30, 2022 2023 (a) $ 6,149 $ 12,131 2024 12,381 12,267 2025 12,389 12,301 2026 9,005 9,005 2027 1,324 1,323 Total future minimum lease payments 41,248 47,027 Less: imputed interest 2,898 3,445 Total operating lease liabilities (b) $ 38,350 $ 43,582 _________________________________ (a) As of December 31, 2022, future minimum lease payments are for the period from January 1, 2023 to June 30, 2023. (b) As of December 31, 2022, total operating lease liabilities included $10.9 million within other current liabilities in the Condensed Consolidated Balance Sheets. Other Matters The Company is not currently involved in any litigation it believes to be material. The Company is periodically involved in litigation, arising in the ordinary course of business or otherwise, which from time to time may include stockholder derivative or other similar litigation, claims relating to commercial, product liability, tort and personal injury, employment, antitrust, intellectual property, or other regulatory matters. If current or future government regulations, including but not limited to those with respect to antitrust or healthcare laws, are interpreted or enforced in a manner adverse to the Company or its business, the Company may be subject to regulatory inquiries or investigations, enforcement actions, penalties and other material limitations which could have a material adverse effect on the Company’s business, financial condition and results of operations.

SEGMENTS

SEGMENTS	6 Months Ended
SEGMENTS	Dec. 31, 2022
Segment Reporting [Abstract]
SEGMENTS	(14) SEGMENTS The Company delivers its solutions and manages its business through two reportable business segments, the Supply Chain Services segment and the Performance Services segment. The Supply Chain Services segment includes the Company’s GPO, supply chain co-management, purchased services and direct sourcing activities. The Performance Services segment consists of three sub-brands: PINC AI , the Company’s technology and services platform; Contigo Health , the Company’s direct-to-employer business; and Remitra , the Company’s digital invoicing and payables business. The following table presents disaggregated revenue by business segment and underlying source (in thousands): Three Months Ended December 31, Six Months Ended December 31, 2022 2021 2022 2021 Net revenue: Supply Chain Services Net administrative fees $ 154,423 $ 150,403 $ 304,429 $ 299,865 Software licenses, other services and support 14,104 9,326 24,931 18,251 Services and software licenses 168,527 159,729 329,360 318,116 Products 66,993 111,766 125,854 230,196 Total Supply Chain Services (a) 235,520 271,495 455,214 548,312 Performance Services Software licenses, other services and support SaaS-based products subscriptions 49,664 48,317 97,412 95,010 Consulting services 18,514 15,105 35,876 30,098 Software licenses 30,804 23,464 36,797 31,864 Other (b) 25,133 20,843 48,219 39,087 Total Performance Services (a) 124,115 107,729 218,304 196,059 Total segment net revenue 359,635 379,224 673,518 744,371 Eliminations (a) (9) (9) (19) (9) Net revenue $ 359,626 $ 379,215 $ 673,499 $ 744,362 _________________________________ (a) Includes intersegment revenue that is eliminated in consolidation. Intersegment revenue is not separately identified in Segments as the amounts are not material. (b) Includes revenue from Contigo Health, Remitra and other PINC AI revenue. Additional segment information related to depreciation and amortization expense, capital expenditures and total assets was as follows (in thousands): Three Months Ended December 31, Six Months Ended December 31, 2022 2021 2022 2021 Depreciation and amortization expense (a) : Supply Chain Services $ 13,610 $ 13,452 $ 27,860 $ 26,596 Performance Services 18,802 16,076 36,218 32,186 Corporate 2,074 2,192 4,299 4,423 Total depreciation and amortization expense $ 34,486 $ 31,720 $ 68,377 $ 63,205 Capital expenditures: Supply Chain Services $ 6,280 $ 7,315 $ 13,015 $ 15,472 Performance Services 13,079 12,363 25,265 23,386 Corporate 127 1,932 136 3,802 Total capital expenditures $ 19,486 $ 21,610 $ 38,416 $ 42,660 December 31, 2022 June 30, 2022 Total assets: Supply Chain Services $ 1,380,072 $ 1,406,108 Performance Services 1,256,795 1,054,687 Corporate 902,531 896,336 Total assets 3,539,398 3,357,131 Eliminations (b) (4) (4) Total assets, net $ 3,539,394 $ 3,357,127 _________________________________ (a) Includes amortization of purchased intangible assets. (b) Includes eliminations of intersegment transactions which occur during the ordinary course of business. The Company uses Segment Adjusted EBITDA (a financial measure not determined in accordance with generally accepted accounting principles (“Non-GAAP”)) as its primary measure of profit or loss to assess segment performance and to determine the allocation of resources. The Company also uses Segment Adjusted EBITDA to facilitate the comparison of the segment operating performance on a consistent basis from period to period. The Company defines Segment Adjusted EBITDA as the segment’s net revenue less cost of revenue and operating expenses directly attributable to the segment excluding depreciation and amortization, amortization of purchased intangible assets, merger and acquisition-related expenses, and non-recurring or non-cash items, and including equity in net income of unconsolidated affiliates. Operating expenses directly attributable to the segment include expenses associated with sales and marketing, general and administrative, and product development activities specific to the operation of each segment. General and administrative corporate expenses that are not specific to a particular segment are not included in the calculation of Segment Adjusted EBITDA. Segment Adjusted EBITDA also excludes any income and expense that has been classified as discontinued operations. For more information on Segment Adjusted EBITDA and the use of Non-GAAP financial measures, see “Our Use of Non-GAAP Financial Measures” within Item 2 - Management's Discussion and Analysis of Financial Condition and Results of Operations. A reconciliation of income before income taxes to unaudited Segment Adjusted EBITDA, a Non-GAAP financial measure, is as follows (in thousands): Three Months Ended December 31, Six Months Ended December 31, 2022 2021 2022 2021 Income before income taxes $ 88,139 $ 83,599 $ 149,867 $ 223,938 Equity in net income of unconsolidated affiliates (a) (1,674) (6,116) (9,917) (13,174) Interest expense, net 4,631 2,873 7,490 5,661 Gain on FFF Put and Call Rights (b) — — — (64,110) Other expense, net (2,930) (2,392) (766) (2,072) Operating income 88,166 77,964 146,674 150,243 Depreciation and amortization 21,439 20,870 44,878 41,466 Amortization of purchased intangible assets 13,047 10,850 23,499 21,739 Stock-based compensation (c) 2,801 16,330 10,150 24,081 Acquisition- and disposition-related expenses 3,138 3,746 5,298 7,167 Strategic initiative and financial restructuring-related expenses 7,527 3,749 9,046 3,774 Equity in net income of unconsolidated affiliates (a) 1,674 6,116 9,917 13,174 Deferred compensation plan income (d) 2,659 2,389 289 2,071 Other reconciling items, net 85 2 165 4 Non-GAAP Adjusted EBITDA $ 140,536 $ 142,016 $ 249,916 $ 263,719 Segment Non-GAAP Adjusted EBITDA: Supply Chain Services (e) $ 127,991 $ 134,280 $ 249,188 $ 263,549 Performance Services (e) 43,203 39,010 62,569 62,725 Corporate (30,658) (31,274) (61,841) (62,555) Non-GAAP Adjusted EBITDA $ 140,536 $ 142,016 $ 249,916 $ 263,719 _________________________________ (a) Refer to Note 4 - Investments for more information. (b) Refer to Note 5 - Fair Value Measurements for more information. (c) Includes non-cash employee stock-based compensation expense and stock purchase plan expense of $0.1 million for the three months ended December 31, 2022 and 2021 and $0.3 million for the six months ended December 31, 2022 and 2021. (d) Represents realized and unrealized gains and losses and dividend income on deferred compensation plan assets. (e) Includes intersegment revenue which is eliminated in consolidation.

SIGNIFICANT ACCOUNTING POLICI_2

SIGNIFICANT ACCOUNTING POLICIES (Policies)	6 Months Ended
SIGNIFICANT ACCOUNTING POLICIES (Policies)	Dec. 31, 2022
Accounting Policies [Abstract]
Principles of Consolidation	Principles of Consolidation The accompanying condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the SEC and in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and include the assets, liabilities, revenues and expenses of all majority-owned subsidiaries over which the Company exercised control and when applicable, entities for which the Company had a controlling financial interest or was the primary beneficiary. All intercompany transactions have been eliminated upon consolidation. Accordingly, certain information and disclosures normally included in annual financial statements have been condensed or omitted. The accompanying condensed consolidated financial statements reflect all adjustments that, in the opinion of management, are necessary for a fair presentation of results of operations and financial condition for the interim periods shown, consisting of normal recurring adjustments, unless otherwise disclosed. The Company believes that the disclosures are adequate to make the information presented not misleading and should be read in conjunction with the audited consolidated financial statements and related footnotes contained in the 2022 Annual Report.
Use of Estimates in the Preparation of Financial Statements	Use of Estimates in the Preparation of Financial StatementsThe preparation of the Company’s condensed consolidated financial statements in accordance with GAAP requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses and related disclosure of contingent assets and liabilities. Significant estimates are evaluated on an ongoing basis, including, but not limited to, estimates for net administrative fees revenue, software licenses, other services and support revenue, contract assets, deferred revenue, contract costs, allowances for credit losses, reserves for net realizable value of inventory, obsolete inventory, useful lives of property and equipment, stock-based compensation, deferred tax balances including valuation allowances on deferred tax assets, uncertain tax positions, values of investments not publicly traded, projected future cash flows used in the evaluation of asset impairments, values of call rights, values of earn-out liabilities and the allocation of purchase prices. These estimates are based on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates.
Recently Adopted Accounting Standards	Recently Adopted Accounting Standards In October 2021, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2021-08 Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers, (“ASU 2021-08”), which requires that an acquirer recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with Topic 606, Revenue from Contracts with Customers. The Company adopted ASU 2021-08 during the second quarter of fiscal 2023. The standard did not have a material impact on the Company’s financial statements nor its related disclosures.

ORGANIZATION (Tables)

ORGANIZATION (Tables)	6 Months Ended
ORGANIZATION (Tables)	Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of Supplemental Cash Flow Information	The following table presents supplementary cash flows information for the six months ended December 31, 2022 and 2021 (in thousands): Six Months Ended December 31, 2022 2021 Supplemental schedule of non-cash investing and financing activities: Increase in treasury stock related to a payable as a result of applying trade date accounting when recording the repurchase of Class A common stock $ — $ 2,108 Non-cash additions to property and equipment 84 8 Accrued dividend equivalents 519 244

INVESTMENTS (Tables)

INVESTMENTS (Tables)	6 Months Ended
INVESTMENTS (Tables)	Dec. 31, 2022
Equity Method Investments and Joint Ventures [Abstract]
Schedule of Investments in Unconsolidated Affiliates	The Company’s investments in unconsolidated affiliates consisted of the following (in thousands): Equity in Net Income Three Months Ended Six Months Ended Carrying Value December 31, December 31, December 31, 2022 June 30, 2022 2022 2021 2022 2021 FFF $ 135,214 $ 137,162 $ 518 $ 3,454 $ 7,705 $ 9,399 Exela 28,503 27,733 632 1,003 770 1,003 Qventus 16,000 16,000 — — — — Prestige 16,068 15,597 291 1,579 471 2,337 Other investments 21,325 19,053 233 80 971 435 Total investments $ 217,110 $ 215,545 $ 1,674 $ 6,116 $ 9,917 $ 13,174

FAIR VALUE MEASUREMENTS (Tables

FAIR VALUE MEASUREMENTS (Tables)	6 Months Ended
FAIR VALUE MEASUREMENTS (Tables)	Dec. 31, 2022
Fair Value Disclosures [Abstract]
Schedule of Financial Assets and Liabilities	The following table represents the Company’s financial assets and liabilities, which are measured at fair value on a recurring basis (in thousands): Fair Value of Financial Assets and Liabilities Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs December 31, 2022 Cash equivalents $ 76 $ 76 $ — $ — Deferred compensation plan assets 49,475 49,475 — — Total assets 49,551 49,551 — — Earn-out liabilities 24,098 — — 24,098 Total liabilities $ 24,098 $ — $ — $ 24,098 June 30, 2022 Cash equivalents $ 75 $ 75 $ — $ — Deferred compensation plan assets 52,718 52,718 — — Total assets 52,793 52,793 — — Earn-out liabilities 22,789 — — 22,789 Total liabilities $ 22,789 $ — $ — $ 22,789
Schedule of Fair Value Measurement Inputs and Valuation Assumptions	Acurity and Nexera Earn-out (a) Input assumptions As of December 31, 2022 As of June 30, 2022 Probability of transferred member renewal percentage < 50% 5.0 % 5.0 % Probability of transferred member renewal percentage between 50% and 65% 10.0 % 10.0 % Probability of transferred member renewal percentage between 65% and 80% 25.0 % 25.0 % Probability of transferred member renewal percentage > 80% 60.0 % 60.0 % Credit spread 1.4 % 1.6 % _________________________________ (a) The Acurity and Nexera earn-out liability was initially valued as of February 28, 2020.
Schedule of Reconciliation of Earn-out Liabilities and FFF Put Rights	A reconciliation of the Company’s Put Right and earn-out liabilities is as follows (in thousands): Beginning Balance Purchases (Settlements) (a) (Gain)/Loss (b) Ending Balance Three Months Ended December 31, 2022 Earn-out liabilities $ 22,361 $ 1,460 $ 277 $ 24,098 Total Level 3 liabilities $ 22,361 $ 1,460 $ 277 $ 24,098 Three Months Ended December 31, 2021 Earn-out liabilities $ 24,368 $ — $ (229) $ 24,139 Total Level 3 liabilities $ 24,368 $ — $ (229) $ 24,139 Six Months Ended December 31, 2022 Earn-out liabilities $ 22,789 $ 1,460 $ (151) $ 24,098 Total Level 3 liabilities $ 22,789 $ 1,460 $ (151) $ 24,098 Six Months Ended December 31, 2021 Earn-out liabilities $ 24,249 $ — $ (110) $ 24,139 FFF put right 64,110 (64,110) — — Total Level 3 liabilities $ 88,359 $ (64,110) $ (110) $ 24,139 _________________________________ (a) Purchases for the three and six months ended December 31, 2022 includes an earn-out which has not been earned or paid as of December 31, 2022. Settlements for the six months ended December 31, 2021 includes non-cash gain recognized as a result the termination of the FFF Put Right and the derecognition of the FFF Put Right liability.
Schedule of Reconciliation of FFF Call Rights	A reconciliation of the Company’s Put Right and earn-out liabilities is as follows (in thousands): Beginning Balance Purchases (Settlements) (a) (Gain)/Loss (b) Ending Balance Three Months Ended December 31, 2022 Earn-out liabilities $ 22,361 $ 1,460 $ 277 $ 24,098 Total Level 3 liabilities $ 22,361 $ 1,460 $ 277 $ 24,098 Three Months Ended December 31, 2021 Earn-out liabilities $ 24,368 $ — $ (229) $ 24,139 Total Level 3 liabilities $ 24,368 $ — $ (229) $ 24,139 Six Months Ended December 31, 2022 Earn-out liabilities $ 22,789 $ 1,460 $ (151) $ 24,098 Total Level 3 liabilities $ 22,789 $ 1,460 $ (151) $ 24,098 Six Months Ended December 31, 2021 Earn-out liabilities $ 24,249 $ — $ (110) $ 24,139 FFF put right 64,110 (64,110) — — Total Level 3 liabilities $ 88,359 $ (64,110) $ (110) $ 24,139 _________________________________ (a) Purchases for the three and six months ended December 31, 2022 includes an earn-out which has not been earned or paid as of December 31, 2022. Settlements for the six months ended December 31, 2021 includes non-cash gain recognized as a result the termination of the FFF Put Right and the derecognition of the FFF Put Right liability.

GOODWILL AND INTANGIBLE ASSETS

GOODWILL AND INTANGIBLE ASSETS (Tables)	6 Months Ended
GOODWILL AND INTANGIBLE ASSETS (Tables)	Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill	Goodwill consisted of the following (in thousands): Supply Chain Services Performance Services Total June 30, 2022 $ 388,502 $ 611,411 $ 999,913 Acquisition of businesses and assets — 69,387 69,387 December 31, 2022 $ 388,502 $ 680,798 $ 1,069,300
Schedule of Finite-Lived Intangible Assets	Intangible assets, net consisted of the following (in thousands): Useful Life December 31, 2022 June 30, 2022 Member relationships 14.7 years $ 386,100 $ 386,100 Provider network 15.0 years 106,500 — Technology 7.1 years 99,317 98,017 Customer relationships 9.4 years 58,030 47,830 Non-compete agreements 5.2 years 17,715 17,315 Trade names 6.8 years 17,410 17,210 Other (a) 9.5 years 8,905 7,682 Total intangible assets 693,977 574,154 Accumulated amortization (241,132) (217,582) Total intangible assets, net $ 452,845 $ 356,572 _________________________________ (a) Includes a $1.0 million indefinite-lived asset. The net carrying value of intangible assets by segment was as follows (in thousands): December 31, 2022 June 30, 2022 Supply Chain Services $ 285,571 $ 301,611 Performance Services (a) 167,274 54,961 Total intangible assets, net $ 452,845 $ 356,572 _________________________________ (a) Includes a $1.0 million indefinite-lived asset.
Schedule of Indefinite-Lived Intangible Assets	Intangible assets, net consisted of the following (in thousands): Useful Life December 31, 2022 June 30, 2022 Member relationships 14.7 years $ 386,100 $ 386,100 Provider network 15.0 years 106,500 — Technology 7.1 years 99,317 98,017 Customer relationships 9.4 years 58,030 47,830 Non-compete agreements 5.2 years 17,715 17,315 Trade names 6.8 years 17,410 17,210 Other (a) 9.5 years 8,905 7,682 Total intangible assets 693,977 574,154 Accumulated amortization (241,132) (217,582) Total intangible assets, net $ 452,845 $ 356,572 _________________________________ (a) Includes a $1.0 million indefinite-lived asset. The net carrying value of intangible assets by segment was as follows (in thousands): December 31, 2022 June 30, 2022 Supply Chain Services $ 285,571 $ 301,611 Performance Services (a) 167,274 54,961 Total intangible assets, net $ 452,845 $ 356,572 _________________________________ (a) Includes a $1.0 million indefinite-lived asset.
Schedule of Estimated Aggregate Amortization Expense	The estimated amortization expense for each of the next five fiscal years and thereafter is as follows (in thousands): 2023 (a) $ 24,407 2024 49,414 2025 47,788 2026 46,544 2027 43,893 Thereafter 239,799 Total amortization expense $ 451,845 (a) As of December 31, 2022, estimated amortization expense is for the period from January 1, 2023 to June 30, 2023.

DEBT AND NOTES PAYABLE (Tables)

DEBT AND NOTES PAYABLE (Tables)	6 Months Ended
DEBT AND NOTES PAYABLE (Tables)	Dec. 31, 2022
Debt Disclosure [Abstract]
Schedule of Long-term Debt and Notes Payable	Long-term debt and notes payable consisted of the following (in thousands): December 31, 2022 June 30, 2022 Credit facility $ 300,000 $ 150,000 Notes payable to members, net of discount 250,324 298,994 Other notes payable 2,954 5,333 Total debt and notes payable 553,278 454,327 Less: current portion (400,682) (250,859) Total long-term debt and notes payable $ 152,596 $ 203,468

EARNINGS PER SHARE (Tables)

EARNINGS PER SHARE (Tables)	6 Months Ended
EARNINGS PER SHARE (Tables)	Dec. 31, 2022
Earnings Per Share [Abstract]
Schedule of Reconciliation of Common Shares Used for Earnings Per Share	The following table provides a reconciliation of the numerator and denominator used for basic and diluted earnings per share (in thousands, except per share amounts): Three Months Ended December 31, Six Months Ended December 31, 2022 2021 2022 2021 Numerator for basic earnings per share: Net income attributable to stockholders (a) $ 64,046 $ 75,545 $ 106,762 $ 197,549 Numerator for diluted earnings per share: Net income attributable to stockholders (a) $ 64,046 $ 75,545 $ 106,762 $ 197,549 Net loss attributable to non-controlling interest — — — 989 Net income for diluted earnings per share $ 64,046 $ 75,545 $ 106,762 $ 198,538 Three Months Ended December 31, Six Months Ended December 31, 2022 2021 2022 2021 Denominator for earnings per share: Basic weighted average shares outstanding (b) 118,787 121,181 118,569 122,063 Effect of dilutive securities: (c) Stock options 86 267 116 288 Restricted stock 466 540 514 516 Performance share awards 313 485 643 656 Diluted weighted average shares and assumed conversions 119,652 122,473 119,842 123,523 Earnings per share attributable to stockholders: Basic $ 0.54 $ 0.62 $ 0.90 $ 1.62 Diluted $ 0.54 $ 0.62 $ 0.89 $ 1.61 _________________________________ (a) Net income attributable to stockholders was calculated as follows (in thousands): Three Months Ended December 31, Six Months Ended December 31, 2022 2021 2022 2021 Net income $ 64,374 $ 77,232 $ 107,333 $ 198,538 Net income attributable to non-controlling interest (328) (1,687) (571) (989) Net income attributable to stockholders $ 64,046 $ 75,545 $ 106,762 $ 197,549 (b) Weighted average number of common shares used for basic earnings per share excludes the impact of all potentially issuable dilutive shares of Class A common stock for the three and six months ended December 31, 2022 and 2021. (c) For the three and six months ended December 31, 2022, the effect of 0.5 million and 0.7 million stock options and restricted stock units, respectively, was excluded from diluted weighted average shares outstanding as it had an anti-dilutive effect. Additionally, for the three and six months ended December 31, 2022, the effect of 0.2 million and 0.3 million performance share awards, respectively, was excluded from diluted weighted average shares outstanding as the awards had not satisfied the applicable performance criteria at the end of the period. For the six months ended December 31, 2021, the effect of 0.3 million stock options and restricted stock units was excluded from diluted weighted average shares outstanding as it had an anti-dilutive effect. Additionally, for the three and six months ended December 31, 2021 the effect of 0.2 million and 0.4 million performance share awards, respectively, was excluded from diluted weighted average shares outstanding as the awards had not satisfied the applicable performance criteria at the end of the period.

STOCK-BASED COMPENSATION (Table

STOCK-BASED COMPENSATION (Tables)	6 Months Ended
STOCK-BASED COMPENSATION (Tables)	Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]
Schedule of Stock-based Compensation Expense and Resulting Tax Benefits	Stock-based compensation expense and the resulting deferred tax benefits were as follows (in thousands): Three Months Ended December 31, Six Months Ended December 31, 2022 2021 2022 2021 Pre-tax stock-based compensation expense $ 2,679 $ 16,234 $ 9,815 $ 23,788 Less: deferred tax benefit (a) 1,060 3,650 2,007 4,725 Total stock-based compensation expense, net of tax $ 1,619 $ 12,584 $ 7,808 $ 19,063 _________________________________ (a) For the three and six months ended December 31, 2022, the deferred tax benefit was increased by $0.4 million and reduced by $0.5 million, respectively, attributable to stock-based compensation expense that is nondeductible for tax purposes pursuant to Section 162(m) as amended by the Tax Cuts and Jobs Act of 2017.
Schedule of Information Related to Restricted Stock	The following table includes information related to restricted stock, performance share awards and stock options for the six months ended December 31, 2022: Restricted Stock Performance Share Awards Stock Options Number of Awards Weighted Average Fair Value at Grant Date Number of Awards Weighted Average Fair Value at Grant Date Number of Options Weighted Average Exercise Price Outstanding at June 30, 2022 1,201,130 $ 35.59 1,578,795 $ 33.66 896,354 $ 30.38 Granted 408,420 36.78 823,009 35.34 — — Vested/exercised (234,842) 36.73 (826,743) 36.35 (24,351) 32.84 Forfeited (50,326) 35.61 (53,538) 32.97 (2,260) 35.65 Outstanding at December 31, 2022 1,324,382 $ 35.75 1,521,523 $ 33.11 869,743 $ 30.30 Stock options outstanding and exercisable at December 31, 2022 869,743 $ 30.30
Schedule of Information Related to Performance Share Awards	The following table includes information related to restricted stock, performance share awards and stock options for the six months ended December 31, 2022: Restricted Stock Performance Share Awards Stock Options Number of Awards Weighted Average Fair Value at Grant Date Number of Awards Weighted Average Fair Value at Grant Date Number of Options Weighted Average Exercise Price Outstanding at June 30, 2022 1,201,130 $ 35.59 1,578,795 $ 33.66 896,354 $ 30.38 Granted 408,420 36.78 823,009 35.34 — — Vested/exercised (234,842) 36.73 (826,743) 36.35 (24,351) 32.84 Forfeited (50,326) 35.61 (53,538) 32.97 (2,260) 35.65 Outstanding at December 31, 2022 1,324,382 $ 35.75 1,521,523 $ 33.11 869,743 $ 30.30 Stock options outstanding and exercisable at December 31, 2022 869,743 $ 30.30
Schedule of Information Related to Stock Options	The following table includes information related to restricted stock, performance share awards and stock options for the six months ended December 31, 2022: Restricted Stock Performance Share Awards Stock Options Number of Awards Weighted Average Fair Value at Grant Date Number of Awards Weighted Average Fair Value at Grant Date Number of Options Weighted Average Exercise Price Outstanding at June 30, 2022 1,201,130 $ 35.59 1,578,795 $ 33.66 896,354 $ 30.38 Granted 408,420 36.78 823,009 35.34 — — Vested/exercised (234,842) 36.73 (826,743) 36.35 (24,351) 32.84 Forfeited (50,326) 35.61 (53,538) 32.97 (2,260) 35.65 Outstanding at December 31, 2022 1,324,382 $ 35.75 1,521,523 $ 33.11 869,743 $ 30.30 Stock options outstanding and exercisable at December 31, 2022 869,743 $ 30.30
Schedule of Unrecognized Stock-based Compensation Expense	Unrecognized stock-based compensation expense at December 31, 2022 was as follows (in thousands). At December 31, 2022, there was no unrecognized stock-based compensation expense for outstanding stock options. Unrecognized Stock-Based Compensation Expense Weighted Average Amortization Period Restricted stock $ 27,707 2.0 years Performance share awards 27,743 2.0 years Total unrecognized stock-based compensation expense $ 55,450 2.0 years
Schedule of Aggregate Intrinsic Value of Stock Options	The aggregate intrinsic value of stock options at December 31, 2022 was as follows (in thousands): Intrinsic Value of Stock Options Outstanding and exercisable $ 4,178 Exercised during the six months ended December 31, 2022 78

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Tables)	6 Months Ended
COMMITMENTS AND CONTINGENCIES (Tables)	Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Schedule of Future Minimum Rental Payments for Operating Leases	Future minimum lease payments under noncancellable operating leases with initial lease terms in excess of one year were as follows (in thousands): December 31, 2022 June 30, 2022 2023 (a) $ 6,149 $ 12,131 2024 12,381 12,267 2025 12,389 12,301 2026 9,005 9,005 2027 1,324 1,323 Total future minimum lease payments 41,248 47,027 Less: imputed interest 2,898 3,445 Total operating lease liabilities (b) $ 38,350 $ 43,582 _________________________________ (a) As of December 31, 2022, future minimum lease payments are for the period from January 1, 2023 to June 30, 2023. (b) As of December 31, 2022, total operating lease liabilities included $10.9 million within other current liabilities in the Condensed Consolidated Balance Sheets.

SEGMENTS (Tables)

SEGMENTS (Tables)	6 Months Ended
SEGMENTS (Tables)	Dec. 31, 2022
Segment Reporting [Abstract]
Schedule of Segment Information	The following table presents disaggregated revenue by business segment and underlying source (in thousands): Three Months Ended December 31, Six Months Ended December 31, 2022 2021 2022 2021 Net revenue: Supply Chain Services Net administrative fees $ 154,423 $ 150,403 $ 304,429 $ 299,865 Software licenses, other services and support 14,104 9,326 24,931 18,251 Services and software licenses 168,527 159,729 329,360 318,116 Products 66,993 111,766 125,854 230,196 Total Supply Chain Services (a) 235,520 271,495 455,214 548,312 Performance Services Software licenses, other services and support SaaS-based products subscriptions 49,664 48,317 97,412 95,010 Consulting services 18,514 15,105 35,876 30,098 Software licenses 30,804 23,464 36,797 31,864 Other (b) 25,133 20,843 48,219 39,087 Total Performance Services (a) 124,115 107,729 218,304 196,059 Total segment net revenue 359,635 379,224 673,518 744,371 Eliminations (a) (9) (9) (19) (9) Net revenue $ 359,626 $ 379,215 $ 673,499 $ 744,362 _________________________________ (a) Includes intersegment revenue that is eliminated in consolidation. Intersegment revenue is not separately identified in Segments as the amounts are not material. (b) Includes revenue from Contigo Health, Remitra and other PINC AI revenue. Additional segment information related to depreciation and amortization expense, capital expenditures and total assets was as follows (in thousands): Three Months Ended December 31, Six Months Ended December 31, 2022 2021 2022 2021 Depreciation and amortization expense (a) : Supply Chain Services $ 13,610 $ 13,452 $ 27,860 $ 26,596 Performance Services 18,802 16,076 36,218 32,186 Corporate 2,074 2,192 4,299 4,423 Total depreciation and amortization expense $ 34,486 $ 31,720 $ 68,377 $ 63,205 Capital expenditures: Supply Chain Services $ 6,280 $ 7,315 $ 13,015 $ 15,472 Performance Services 13,079 12,363 25,265 23,386 Corporate 127 1,932 136 3,802 Total capital expenditures $ 19,486 $ 21,610 $ 38,416 $ 42,660 December 31, 2022 June 30, 2022 Total assets: Supply Chain Services $ 1,380,072 $ 1,406,108 Performance Services 1,256,795 1,054,687 Corporate 902,531 896,336 Total assets 3,539,398 3,357,131 Eliminations (b) (4) (4) Total assets, net $ 3,539,394 $ 3,357,127 _________________________________ (a) Includes amortization of purchased intangible assets.
Schedule of Reconciliation of Income Before Income Taxes to Segment Adjusted EBITDA	A reconciliation of income before income taxes to unaudited Segment Adjusted EBITDA, a Non-GAAP financial measure, is as follows (in thousands): Three Months Ended December 31, Six Months Ended December 31, 2022 2021 2022 2021 Income before income taxes $ 88,139 $ 83,599 $ 149,867 $ 223,938 Equity in net income of unconsolidated affiliates (a) (1,674) (6,116) (9,917) (13,174) Interest expense, net 4,631 2,873 7,490 5,661 Gain on FFF Put and Call Rights (b) — — — (64,110) Other expense, net (2,930) (2,392) (766) (2,072) Operating income 88,166 77,964 146,674 150,243 Depreciation and amortization 21,439 20,870 44,878 41,466 Amortization of purchased intangible assets 13,047 10,850 23,499 21,739 Stock-based compensation (c) 2,801 16,330 10,150 24,081 Acquisition- and disposition-related expenses 3,138 3,746 5,298 7,167 Strategic initiative and financial restructuring-related expenses 7,527 3,749 9,046 3,774 Equity in net income of unconsolidated affiliates (a) 1,674 6,116 9,917 13,174 Deferred compensation plan income (d) 2,659 2,389 289 2,071 Other reconciling items, net 85 2 165 4 Non-GAAP Adjusted EBITDA $ 140,536 $ 142,016 $ 249,916 $ 263,719 Segment Non-GAAP Adjusted EBITDA: Supply Chain Services (e) $ 127,991 $ 134,280 $ 249,188 $ 263,549 Performance Services (e) 43,203 39,010 62,569 62,725 Corporate (30,658) (31,274) (61,841) (62,555) Non-GAAP Adjusted EBITDA $ 140,536 $ 142,016 $ 249,916 $ 263,719 _________________________________ (a) Refer to Note 4 - Investments for more information. (b) Refer to Note 5 - Fair Value Measurements for more information. (c) Includes non-cash employee stock-based compensation expense and stock purchase plan expense of $0.1 million for the three months ended December 31, 2022 and 2021 and $0.3 million for the six months ended December 31, 2022 and 2021. (d) Represents realized and unrealized gains and losses and dividend income on deferred compensation plan assets. (e) Includes intersegment revenue which is eliminated in consolidation.

ORGANIZATION - Narrative (Detai

ORGANIZATION - Narrative (Details)	6 Months Ended
ORGANIZATION - Narrative (Details)	Dec. 31, 2022 brand segment
Segment Reporting Information [Line Items]
Number of business segments \| segment	2
Performance Services
Segment Reporting Information [Line Items]
Number of sub-brands \| brand	3

ORGANIZATION - Supplementary Ca

ORGANIZATION - Supplementary Cash Flow Information (Details) - USD ($) $ in Thousands	6 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Supplemental schedule of non-cash investing and financing activities:
Increase in treasury stock related to a payable as a result of applying trade date accounting when recording the repurchase of Class A common stock	$ 0	$ 2,108
Non-cash additions to property and equipment	84	8
Accrued dividend equivalents	$ 519	$ 244

BUSINESS ACQUISITIONS (Details)

BUSINESS ACQUISITIONS (Details) $ in Thousands	Oct. 13, 2022 USD ($) provider	Dec. 31, 2022 USD ($)	Jun. 30, 2022 USD ($)
Asset Acquisition, Contingent Consideration [Line Items]
Goodwill		$ 1,069,300	$ 999,913
TRPN Transferred Assets
Asset Acquisition, Contingent Consideration [Line Items]
Number of TRPN contracts \| provider	900,000
Transferring cash	$ 177,500
Escrow account satisfy indemnification obligations	17,800
Fair value of intangible assets acquired	116,600
Goodwill	$ 60,900

INVESTMENTS - Schedule of Inves

INVESTMENTS - Schedule of Investments in Unconsolidated Affiliates (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021	Jun. 30, 2022
Schedule of Equity Method Investments [Line Items]
Carrying Value	$ 217,110		$ 217,110		$ 215,545
Equity in Net Income	1,674	$ 6,116	9,917	$ 13,174
FFF
Schedule of Equity Method Investments [Line Items]
Carrying Value	135,214		135,214		137,162
Equity in Net Income	518	3,454	7,705	9,399
Exela
Schedule of Equity Method Investments [Line Items]
Carrying Value	28,503		28,503		27,733
Equity in Net Income	632	1,003	770	1,003
Qventus
Schedule of Equity Method Investments [Line Items]
Carrying Value	16,000		16,000		16,000
Equity in Net Income	0	0	0	0
Prestige
Schedule of Equity Method Investments [Line Items]
Carrying Value	16,068		16,068		15,597
Equity in Net Income	291	1,579	471	2,337
Other investments
Schedule of Equity Method Investments [Line Items]
Carrying Value	21,325		21,325		$ 19,053
Equity in Net Income	$ 233	$ 80	$ 971	$ 435

INVESTMENTS - Narrative (Detail

INVESTMENTS - Narrative (Details) - health_system	Dec. 31, 2022	Jun. 30, 2022
FFF
Schedule of Equity Method Investments [Line Items]
Ownership interest through subsidiary (as a percent)	49%	49%
ExPre Holdings, LLC
Schedule of Equity Method Investments [Line Items]
Ownership interest through subsidiary (as a percent)	15%
Number of member health systems	11
PRAM Holdings, LLC
Schedule of Equity Method Investments [Line Items]
Ownership interest through subsidiary (as a percent)	26%
Number of member health systems	16
Qventus
Schedule of Equity Method Investments [Line Items]
Ownership interest through subsidiary (as a percent)	7%
ExPre Holdings, LLC \| Exela
Schedule of Equity Method Investments [Line Items]
Ownership interest through subsidiary (as a percent)	6%
PRAM Holdings, LLC \| Prestige
Schedule of Equity Method Investments [Line Items]
Ownership interest through subsidiary (as a percent)	20%

FAIR VALUE MEASUREMENTS - Sched

FAIR VALUE MEASUREMENTS - Schedule of Financial Assets and Liabilities (Details) - Recurring - USD ($) $ in Thousands	Dec. 31, 2022	Jun. 30, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	$ 76	$ 75
Deferred compensation plan assets	49,475	52,718
Total assets	49,551	52,793
Earn-out liabilities	24,098	22,789
Total liabilities	24,098	22,789
Quoted Prices in Active Markets for Identical Assets (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	76	75
Deferred compensation plan assets	49,475	52,718
Total assets	49,551	52,793
Earn-out liabilities	0	0
Total liabilities	0	0
Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	0	0
Deferred compensation plan assets	0	0
Total assets	0	0
Earn-out liabilities	0	0
Total liabilities	0	0
Significant Unobservable Inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	0	0
Deferred compensation plan assets	0	0
Total assets	0	0
Earn-out liabilities	24,098	22,789
Total liabilities	$ 24,098	$ 22,789

FAIR VALUE MEASUREMENTS - Narra

FAIR VALUE MEASUREMENTS - Narrative (Details)	6 Months Ended
FAIR VALUE MEASUREMENTS - Narrative (Details)	Dec. 31, 2022 USD ($)	Jun. 30, 2022 USD ($)	Aug. 11, 2020
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assumed market interest rate (percent)	1.60%	1.60%
Notes payable to members, net of discount \| Notes Payable, Other Payables
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt discount	$ 6,400,000	$ 9,100,000
Acurity, Inc. (“Acurity”) and Nexera, Inc. (“Nexera”)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Earn-out liabilities	22,600,000	22,800,000
Acurity, Inc. (“Acurity”) and Nexera, Inc. (“Nexera”) \| Minimum
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Earn-out liabilities	$ 0	$ 30,000,000
Credit spread \| Valuation Technique, Estimated Future Earnings \| Acurity, Inc. (“Acurity”) and Nexera, Inc. (“Nexera”)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Earn-out input assumptions (percent)	0.014	0.016
FFF Call Right
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Call right, exercisable term, key event (in days)	180 days
Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
FFF call right	$ 0	$ 0
Earn-out liabilities	24,098,000	22,789,000
Level 1 \| Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Earn-out liabilities	0	0
Level 1 \| Prepaid Expenses and Other Current Assets \| Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Current portion of deferred compensation plan assets	4,900,000	5,300,000
Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Imputed interest (percent)			1.80%
Notes payable, difference between fair value and carrying value		100,000
Level 2 \| Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Earn-out liabilities	$ 0	$ 0

FAIR VALUE MEASUREMENTS - Fair

FAIR VALUE MEASUREMENTS - Fair Value Measurement Input Assumptions (Details) - Valuation Technique, Estimated Future Earnings - Acurity, Inc. (“Acurity”) and Nexera, Inc. (“Nexera”)	Dec. 31, 2022	Jun. 30, 2022
Probability of transferred member renewal percentage less than 50%
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Earn-out input assumptions (percent)	0.050	0.050
Probability of transferred member renewal percentage between 50% and 65%
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Earn-out input assumptions (percent)	0.100	0.100
Probability of transferred member renewal percentage between 65% and 80%
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Earn-out input assumptions (percent)	0.250	0.250
Probability of transferred member renewal percentage greater than 80%
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Earn-out input assumptions (percent)	0.600	0.600
Credit spread
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Earn-out input assumptions (percent)	0.014	0.016

FAIR VALUE MEASUREMENTS - Recon

FAIR VALUE MEASUREMENTS - Reconciliation of Earn-Out Liabilities and FFF Put and Call Rights (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation
Beginning Balance	$ 22,361	$ 24,368	$ 22,789	$ 88,359
Purchases (Settlements)	1,460	0	1,460	(64,110)
(Gain) Loss	277	(229)	(151)	(110)
Ending Balance	24,098	24,139	$ 24,098	$ 24,139
Fair Value, Asset, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]			Nonoperating Income (Expense)	Nonoperating Income (Expense)
Earn-out liabilities
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation
Beginning Balance	22,361	24,368	$ 22,789	$ 24,249
Purchases (Settlements)	1,460	0	1,460	0
(Gain) Loss	277	(229)	(151)	(110)
Ending Balance	$ 24,098	24,139	$ 24,098	24,139
FFF put right
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation
Beginning Balance				64,110
Purchases (Settlements)				(64,110)
(Gain) Loss				0
Ending Balance		$ 0		$ 0

CONTRACT BALANCES - Contract As

CONTRACT BALANCES - Contract Assets, Deferred Revenue and Capitalized Contract Costs (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue recognized		$ 8.1	$ 23.3	$ 3.7
Revenue recognized from performance obligations satisfied in previous periods	$ (0.4)		2.5
Revenue recognized associated with revised forecasts underlying contracts with variable consideration components	(0.8)		(2.1)
Revenue recognized associated with a change in net administration fee revenue		0.8		0.6
Administrative Fees
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue recognized associated with revised forecasts underlying contracts with variable consideration components		$ 7.3		$ 3.1
Revenue recognized associated with a change in net administration fee revenue	$ 0.4		$ 4.6

CONTRACT BALANCES - Remaining P

CONTRACT BALANCES - Remaining Performance Obligation (Details) $ in Millions	Dec. 31, 2022 USD ($)
Revenue from Contract with Customer [Abstract]
Transaction price allocated to remaining performance obligation	$ 700.6
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligation to be satisfied (percent)	42%
Remaining performance obligation satisfaction period (in months)	12 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligation to be satisfied (percent)	23%
Remaining performance obligation satisfaction period (in months)	12 months

GOODWILL AND INTANGIBLE ASSET_2

GOODWILL AND INTANGIBLE ASSETS - Schedule of Goodwill (Details) $ in Thousands	6 Months Ended
	Dec. 31, 2022 USD ($)
Goodwill [Roll Forward]
Goodwill beginning balance	$ 999,913
Acquisition of businesses and assets	69,387
Goodwill ending balance	1,069,300
Supply Chain Services
Goodwill [Roll Forward]
Goodwill beginning balance	388,502
Acquisition of businesses and assets	0
Goodwill ending balance	388,502
Performance Services
Goodwill [Roll Forward]
Goodwill beginning balance	611,411
Acquisition of businesses and assets	69,387
Goodwill ending balance	$ 680,798

GOODWILL AND INTANGIBLE ASSET_3

GOODWILL AND INTANGIBLE ASSETS - Narrative (Details) - USD ($) $ in Thousands		3 Months Ended		6 Months Ended
	Oct. 13, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021
Goodwill [Line Items]
Intangible asset amortization		$ 13,047	$ 10,850	$ 23,499	$ 21,739
TRPN Transferred Assets
Goodwill [Line Items]
Fair value of intangible assets acquired	$ 116,600
Weighted average useful life of the acquired intangible assets	14 years 1 month 6 days
TRPN Transferred Assets \| Provider network
Goodwill [Line Items]
Fair value of intangible assets acquired	$ 106,500
Weighted average useful life of the acquired intangible assets	15 years

GOODWILL AND INTANGIBLE ASSET_4

GOODWILL AND INTANGIBLE ASSETS - Intangible Assets (Details) - USD ($) $ in Thousands	6 Months Ended
	Dec. 31, 2022	Jun. 30, 2022
Finite-Lived Intangible Assets [Line Items]
Total intangible assets	$ 693,977	$ 574,154
Accumulated amortization	(241,132)	(217,582)
Total intangible assets, net	452,845	356,572
Other
Finite-Lived Intangible Assets [Line Items]
Indefinite-lived intangible asset	$ 1,000
Member relationships
Finite-Lived Intangible Assets [Line Items]
Useful Life	14 years 8 months 12 days
Total intangible assets	$ 386,100	386,100
Provider network
Finite-Lived Intangible Assets [Line Items]
Useful Life	15 years
Total intangible assets	$ 106,500	0
Technology
Finite-Lived Intangible Assets [Line Items]
Useful Life	7 years 1 month 6 days
Total intangible assets	$ 99,317	98,017
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Useful Life	9 years 4 months 24 days
Total intangible assets	$ 58,030	47,830
Non-compete agreements
Finite-Lived Intangible Assets [Line Items]
Useful Life	5 years 2 months 12 days
Total intangible assets	$ 17,715	17,315
Trade names
Finite-Lived Intangible Assets [Line Items]
Useful Life	6 years 9 months 18 days
Total intangible assets	$ 17,410	17,210
Other
Finite-Lived Intangible Assets [Line Items]
Useful Life	9 years 6 months
Total intangible assets	$ 8,905	$ 7,682

GOODWILL AND INTANGIBLE ASSET_5

GOODWILL AND INTANGIBLE ASSETS - Intangible Assets by Segment (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Jun. 30, 2022
Finite-Lived Intangible Assets [Line Items]
Total intangible assets, net	$ 452,845	$ 356,572
Supply Chain Services
Finite-Lived Intangible Assets [Line Items]
Total intangible assets, net	285,571	301,611
Performance Services
Finite-Lived Intangible Assets [Line Items]
Total intangible assets, net	$ 167,274	$ 54,961

GOODWILL AND INTANGIBLE ASSET_6

GOODWILL AND INTANGIBLE ASSETS - Schedule of Estimated Aggregate Amortization Expense (Details) $ in Thousands	Dec. 31, 2022 USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
2023	$ 24,407
2024	49,414
2025	47,788
2026	46,544
2027	43,893
Thereafter	239,799
Total intangible assets, net	$ 451,845

DEBT AND NOTES PAYABLE - Schedu

DEBT AND NOTES PAYABLE - Schedule of Long-Term Debt and Notes Payable (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Jun. 30, 2022
Debt Instrument [Line Items]
Total debt and notes payable	$ 553,278	$ 454,327
Less: current portion	(400,682)	(250,859)
Total long-term debt and notes payable	152,596	203,468
Credit facility
Debt Instrument [Line Items]
Total debt and notes payable	300,000	150,000
Notes Payable \| Notes payable to members, net of discount
Debt Instrument [Line Items]
Total debt and notes payable	250,324	298,994
Notes Payable \| Other notes payable
Debt Instrument [Line Items]
Total debt and notes payable	$ 2,954	$ 5,333

DEBT AND NOTES PAYABLE - Credit

DEBT AND NOTES PAYABLE - Credit Facility (Narrative) (Details)		1 Months Ended		6 Months Ended
	Dec. 12, 2022 USD ($) extension	Jan. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)	Jun. 30, 2022 USD ($)	Nov. 09, 2018 USD ($)
Line of Credit Facility [Line Items]
Outstanding borrowings			$ 553,278,000	$ 553,278,000		$ 454,327,000
Proceeds from credit facility				285,000,000	$ 175,000,000
Payments on credit facility				$ 135,000,000	$ 125,000,000
Credit facility
Line of Credit Facility [Line Items]
Number of available extensions \| extension	2
Duration of each available extension	1 year
Maximum borrowing capacity	$ 1,000,000,000						$ 1,000,000,000
Additional borrowing capacity	350,000,000
Loan fees							$ 331,300,000
Credit facility, unused capacity commitment fee (percent)			0.125%
Weighted average interest rate			5.633%	5.633%
Indebtedness or guarantee threshold	$ 75,000,000
Outstanding borrowings			$ 300,000,000	$ 300,000,000
Available borrowing capacity			$ 699,900,000	699,900,000
Proceeds from credit facility				0
Payments on credit facility				$ 0
Credit facility \| Subsequent Event
Line of Credit Facility [Line Items]
Payments on credit facility		$ 30,000,000
Credit facility \| Minimum
Line of Credit Facility [Line Items]
Credit facility, unused capacity commitment fee (percent)			0.125%
Credit facility \| Maximum
Line of Credit Facility [Line Items]
Credit facility, unused capacity commitment fee (percent)			0.225%
Credit facility \| SOFR
Line of Credit Facility [Line Items]
Basis spread on variable rate	0.10%
Interest rate (percent)			5.708%	5.708%
Credit facility \| SOFR \| Minimum
Line of Credit Facility [Line Items]
Basis spread on variable rate	1.25%
Credit facility \| SOFR \| Maximum
Line of Credit Facility [Line Items]
Basis spread on variable rate	1.75%
Credit facility \| Fed Funds Effective Rate Overnight Index Swap Rate
Line of Credit Facility [Line Items]
Basis spread on variable rate	0.50%
Credit facility \| One-Month Adjusted Secured Overnight Financing Rate
Line of Credit Facility [Line Items]
Basis spread on variable rate	1%
Credit facility \| Base Rate
Line of Credit Facility [Line Items]
Debt instrument, interest rate, stated percentage	0%
Interest rate (percent)			7.75%	7.75%
Credit facility \| Base Rate \| Minimum
Line of Credit Facility [Line Items]
Basis spread on variable rate	0.25%
Credit facility \| Base Rate \| Maximum
Line of Credit Facility [Line Items]
Basis spread on variable rate	0.75%
Letters of credit
Line of Credit Facility [Line Items]
Maximum borrowing capacity	$ 50,000,000
Swing Line Loan
Line of Credit Facility [Line Items]
Maximum borrowing capacity	$ 100,000,000
Prior Loan Agreement
Line of Credit Facility [Line Items]
Proceeds from credit facility				$ 285,000,000
Payments on credit facility				$ 135,000,000

DEBT AND NOTES PAYABLE - Notes

DEBT AND NOTES PAYABLE - Notes Payable (Narrative) (Details) - USD ($) $ in Millions	6 Months Ended
	Dec. 31, 2022	Jun. 30, 2022	Aug. 11, 2020
Level 2
Debt Instrument [Line Items]
Imputed interest (percent)			1.80%
Notes Payable \| Minimum
Debt Instrument [Line Items]
Notes payable, stated maturity period	3 years
Notes Payable \| Maximum
Debt Instrument [Line Items]
Notes payable, stated maturity period	5 years
Notes payable to members, net of discount \| Notes Payable
Debt Instrument [Line Items]
Notes payable	$ 250.3	$ 299
Debt discount	6.4	9.1
Notes payable included in current portion of long-term debt	98.7	97.8
Other notes payable \| Notes Payable
Debt Instrument [Line Items]
Notes payable	3	5.3
Notes payable included in current portion of long-term debt	$ 1.9	$ 3.1

STOCKHOLDERS' EQUITY (Details)

STOCKHOLDERS' EQUITY (Details) - $ / shares		3 Months Ended
STOCKHOLDERS' EQUITY (Details) - $ / shares	Jan. 26, 2023	Dec. 31, 2022	Sep. 30, 2022	Dec. 31, 2021	Sep. 30, 2021	Jun. 30, 2022
Subsequent Event
Class of Stock [Line Items]
Dividends declared (in dollars per share	$ 0.21
Class A Common Stock
Class of Stock [Line Items]
Common stock outstanding (in shares)		118,866,586				118,052,235
Common stock, par value (in dollars per share)		$ 0.01				$ 0.01
Dividends declared (in dollars per share		$ 0.21	$ 0.21	$ 0.20	$ 0.20

EARNINGS PER SHARE - Reconcilia

EARNINGS PER SHARE - Reconciliation of the Numerator and Denominator Used for Basic and Diluted Earnings (Loss) Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended				6 Months Ended
	Dec. 31, 2022	Sep. 30, 2022	Dec. 31, 2021	Sep. 30, 2021	Dec. 31, 2022	Dec. 31, 2021
Numerator for basic earnings per share:
Net income attributable to stockholders	$ 64,046		$ 75,545		$ 106,762	$ 197,549
Numerator for diluted earnings per share:
Net income attributable to stockholders	64,046		75,545		106,762	197,549
Net loss attributable to non-controlling interest	0		0		0	989
Net income for diluted earnings per share	$ 64,046		$ 75,545		$ 106,762	$ 198,538
Denominator for earnings per share:
Basic weighted average shares outstanding (in shares)	118,787		121,181		118,569	122,063
Effect of dilutive securities:
Diluted weighted average shares and assumed conversions (in shares)	119,652		122,473		119,842	123,523
Earnings per share attributable to stockholders:
Basic (in dollars per share)	$ 0.54		$ 0.62		$ 0.90	$ 1.62
Diluted (in dollars per share)	$ 0.54		$ 0.62		$ 0.89	$ 1.61
Net income	$ 64,374	$ 42,959	$ 77,232	$ 121,306	$ 107,333	$ 198,538
Net income attributable to non-controlling interest	(328)		(1,687)		(571)	(989)
Net income attributable to stockholders	$ 64,046		$ 75,545		$ 106,762	$ 197,549
Stock options
Effect of dilutive securities:
Effect of dilutive securities (in shares)	86		267		116	288
Restricted stock
Effect of dilutive securities:
Effect of dilutive securities (in shares)	466		540		514	516
Performance share awards
Effect of dilutive securities:
Effect of dilutive securities (in shares)	313		485		643	656
Earnings per share attributable to stockholders:
Antidilutive securities excluded from computation of earnings per share (in shares)	200		200		300	400
Options and Restricted Stock Units
Earnings per share attributable to stockholders:
Antidilutive securities excluded from computation of earnings per share (in shares)	500				700	300

STOCK-BASED COMPENSATION - Narr

STOCK-BASED COMPENSATION - Narrative (Details) - shares shares in Millions	6 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected effective income tax rate (percent)	26%	26%
2013 Equity Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of awards authorized for grant (up to) (in shares)	14.8
Number of shares available for grant (in shares)	3.9
Performance share awards \| 2013 Equity Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period (in years)	3 years
Stock options \| 2013 Equity Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period (in years)	3 years
Stock options, expiration period	10 years
Stock options \| 2013 Equity Incentive Plan \| Share-Based Payment Arrangement, Tranche One
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options, expiration period	12 months
Stock options \| 2013 Equity Incentive Plan \| Share-Based Payment Arrangement, Tranche Two
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options, expiration period	90 days
Employee \| Restricted Stock \| 2013 Equity Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period (in years)	3 years
Director \| Restricted Stock \| 2013 Equity Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period (in years)	1 year

STOCK-BASED COMPENSATION - Sche

STOCK-BASED COMPENSATION - Schedule of Stock-based Compensation Expense and Resulting Tax Benefits (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021
Share-Based Payment Arrangement [Abstract]
Pre-tax stock-based compensation expense	$ 2,679	$ 16,234	$ 9,815	$ 23,788
Less: deferred tax benefit	1,060	3,650	2,007	4,725
Total stock-based compensation expense, net of tax	1,619	$ 12,584	7,808	$ 19,063
Increase (decrease) in deferred tax benefit	$ 400		$ (500)

STOCK-BASED COMPENSATION - Sc_2

STOCK-BASED COMPENSATION - Schedule of Information Related to Restricted Stock, Performance Share Awards and Stock Options (Details) - 2013 Equity Incentive Plan	6 Months Ended
	Dec. 31, 2022 $ / shares shares
Restricted Stock
Number of Awards
Outstanding, beginning balance (in shares) \| shares	1,201,130
Granted (in shares) \| shares	408,420
Vested/exercised (in shares) \| shares	(234,842)
Forfeited (in shares) \| shares	(50,326)
Outstanding, ending balance (in shares) \| shares	1,324,382
Weighted Average Fair Value at Grant Date
Outstanding, beginning balance (in dollars per share) \| $ / shares	$ 35.59
Granted (in dollars per share) \| $ / shares	36.78
Vested/exercised (in dollars per share) \| $ / shares	36.73
Forfeited (in dollars per share) \| $ / shares	35.61
Outstanding, ending balance (in dollars per share) \| $ / shares	$ 35.75
Performance Share Awards
Number of Awards
Outstanding, beginning balance (in shares) \| shares	1,578,795
Granted (in shares) \| shares	823,009
Vested/exercised (in shares) \| shares	(826,743)
Forfeited (in shares) \| shares	(53,538)
Outstanding, ending balance (in shares) \| shares	1,521,523
Weighted Average Fair Value at Grant Date
Outstanding, beginning balance (in dollars per share) \| $ / shares	$ 33.66
Granted (in dollars per share) \| $ / shares	35.34
Vested/exercised (in dollars per share) \| $ / shares	36.35
Forfeited (in dollars per share) \| $ / shares	32.97
Outstanding, ending balance (in dollars per share) \| $ / shares	$ 33.11
Stock options
Number of Options
Outstanding, beginning balance (in shares) \| shares	896,354
Granted (in shares) \| shares	0
Vested/exercised (in shares) \| shares	(24,351)
Forfeited (in shares) \| shares	(2,260)
Outstanding, ending balance (in shares) \| shares	869,743
Stock options outstanding and exercisable (in shares) \| shares	869,743
Weighted Average Exercise Price
Outstanding, beginning balance (in dollars per share) \| $ / shares	$ 30.38
Granted (in dollars per share) \| $ / shares	0
Vested/exercised (in dollars per share) \| $ / shares	32.84
Forfeited (in dollars per share) \| $ / shares	35.65
Outstanding, ending balance (in dollars per share) \| $ / shares	30.30
Stock options outstanding and exercisable (in dollars per share) \| $ / shares	$ 30.30

STOCK-BASED COMPENSATION - Sc_3

STOCK-BASED COMPENSATION - Schedule of Unrecognized Stock-Based Compensation Expense (Details) $ in Thousands	6 Months Ended
	Dec. 31, 2022 USD ($)
Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized Stock-Based Compensation Expense	$ 0
2013 Equity Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized Stock-Based Compensation Expense	$ 55,450
Weighted Average Amortization Period	2 years
2013 Equity Incentive Plan \| Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized Stock-Based Compensation Expense	$ 27,707
Weighted Average Amortization Period	2 years
2013 Equity Incentive Plan \| Performance share awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized Stock-Based Compensation Expense	$ 27,743
Weighted Average Amortization Period	2 years

STOCK-BASED COMPENSATION - Sc_4

STOCK-BASED COMPENSATION - Schedule of Aggregate Intrinsic Value of Stock Options (Details) - 2013 Equity Incentive Plan $ in Thousands	6 Months Ended
	Dec. 31, 2022 USD ($)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding and exercisable	$ 4,178
Exercised during the six months ended December 31, 2022	$ 78

INCOME TAXES (Details)

INCOME TAXES (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
INCOME TAXES (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021
Income Tax Disclosure [Abstract]
Income tax expense	$ 23,765	$ 6,367	$ 42,534	$ 25,400
Effective tax rate (percent)	27%	8%	28%	11%

COMMITMENTS AND CONTINGENCIES_2

COMMITMENTS AND CONTINGENCIES (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021	Jun. 30, 2022
Commitments and Contingencies Disclosure [Abstract]
Operating lease expense	$ 2,500	$ 2,500	$ 5,000	$ 5,100
Weighted average remaining lease term (in years)	3 years 3 months 18 days		3 years 3 months 18 days
Weighted average discount rate (percent)	4%		4%
Lessee, Operating Lease, Liability, Payment, Due [Abstract]
Remainder of the year	$ 6,149		$ 6,149
Year one	12,381		12,381		$ 12,131
Year two	12,389		12,389		12,267
Year three	9,005		9,005		12,301
Year four	1,324		1,324		9,005
Year five					1,323
Total future minimum lease payments	41,248		41,248		47,027
Less: imputed interest	2,898		2,898		3,445
Total operating lease liabilities	$ 38,350		$ 38,350		$ 43,582
Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]	Other current liabilities		Other current liabilities
Operating lease liability included in other liabilities, current	$ 10,900		$ 10,900

SEGMENTS - Narrative (Details)

SEGMENTS - Narrative (Details)	6 Months Ended
SEGMENTS - Narrative (Details)	Dec. 31, 2022 brand segment
Segment Reporting Information [Line Items]
Number of reportable business segments \| segment	2
Performance Services
Segment Reporting Information [Line Items]
Number of sub-brands \| brand	3

SEGMENTS - Schedule of Segment

SEGMENTS - Schedule of Segment Information (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021	Jun. 30, 2022
Segment Reporting Information [Line Items]
Net revenue	$ 359,626	$ 379,215	$ 673,499	$ 744,362
Total depreciation and amortization expense	34,486	31,720	68,377	63,205
Total capital expenditures	19,486	21,610	38,416	42,660
Total assets	3,539,394		3,539,394		$ 3,357,127
Operating Segments
Segment Reporting Information [Line Items]
Net revenue	359,635	379,224	673,518	744,371
Corporate
Segment Reporting Information [Line Items]
Total depreciation and amortization expense	2,074	2,192	4,299	4,423
Total capital expenditures	127	1,932	136	3,802
Total assets	902,531		902,531		896,336
Eliminations
Segment Reporting Information [Line Items]
Net revenue	(9)	(9)	(19)	(9)
Total assets	(4)		(4)		(4)
Supply Chain Services \| Operating Segments
Segment Reporting Information [Line Items]
Net revenue	235,520	271,495	455,214	548,312
Total depreciation and amortization expense	13,610	13,452	27,860	26,596
Total capital expenditures	6,280	7,315	13,015	15,472
Total assets	1,380,072		1,380,072		1,406,108
Performance Services \| Operating Segments
Segment Reporting Information [Line Items]
Net revenue	124,115	107,729	218,304	196,059
Total depreciation and amortization expense	18,802	16,076	36,218	32,186
Total capital expenditures	13,079	12,363	25,265	23,386
Total assets	1,256,795		1,256,795		1,054,687
Operating Segments and Corporate Non-segment
Segment Reporting Information [Line Items]
Total assets	3,539,398		3,539,398		$ 3,357,131
Net administrative fees
Segment Reporting Information [Line Items]
Net revenue	154,423	150,403	304,429	299,865
Net administrative fees \| Supply Chain Services \| Operating Segments
Segment Reporting Information [Line Items]
Net revenue	154,423	150,403	304,429	299,865
Software licenses, other services and support
Segment Reporting Information [Line Items]
Net revenue	138,210	117,046	243,216	214,301
Software licenses, other services and support \| Supply Chain Services \| Operating Segments
Segment Reporting Information [Line Items]
Net revenue	14,104	9,326	24,931	18,251
Services and software licenses
Segment Reporting Information [Line Items]
Net revenue	292,633	267,449	547,645	514,166
Services and software licenses \| Supply Chain Services \| Operating Segments
Segment Reporting Information [Line Items]
Net revenue	168,527	159,729	329,360	318,116
Products
Segment Reporting Information [Line Items]
Net revenue	66,993	111,766	125,854	230,196
Products \| Supply Chain Services \| Operating Segments
Segment Reporting Information [Line Items]
Net revenue	66,993	111,766	125,854	230,196
SaaS-based products subscriptions \| Performance Services \| Operating Segments
Segment Reporting Information [Line Items]
Net revenue	49,664	48,317	97,412	95,010
Consulting services \| Performance Services \| Operating Segments
Segment Reporting Information [Line Items]
Net revenue	18,514	15,105	35,876	30,098
Software licenses \| Performance Services \| Operating Segments
Segment Reporting Information [Line Items]
Net revenue	30,804	23,464	36,797	31,864
Other \| Performance Services \| Operating Segments
Segment Reporting Information [Line Items]
Net revenue	$ 25,133	$ 20,843	$ 48,219	$ 39,087

SEGMENTS - Reconciliation of In

SEGMENTS - Reconciliation of Income Before Income Taxes to Segment Adjusted EBITDA (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021
Segment Reporting Information [Line Items]
Income before income taxes	$ 88,139	$ 83,599	$ 149,867	$ 223,938
Equity in net income of unconsolidated affiliates	(1,674)	(6,116)	(9,917)	(13,174)
Interest expense, net	4,631	2,873	7,490	5,661
Gain on FFF Put and Call Rights	0	0	0	(64,110)
Other expense, net	(2,930)	(2,392)	(766)	(2,072)
Operating income	88,166	77,964	146,674	150,243
Depreciation and amortization	21,439	20,870	44,878	41,466
Amortization of purchased intangible assets	13,047	10,850	23,499	21,739
Stock-based compensation	2,801	16,330	10,150	24,081
Acquisition- and disposition-related expenses	3,138	3,746	5,298	7,167
Strategic initiative and financial restructuring-related expenses	7,527	3,749	9,046	3,774
Equity in net income of unconsolidated affiliates	1,674	6,116	9,917	13,174
Deferred compensation plan income	2,659	2,389	289	2,071
Other reconciling items, net	85	2	165	4
Non-GAAP Adjusted EBITDA	140,536	142,016	249,916	263,719
Employee Stock Purchase Plan (ESPP)
Segment Reporting Information [Line Items]
Stock-based compensation	100	100	300	300
Operating Segments \| Supply Chain Services
Segment Reporting Information [Line Items]
Non-GAAP Adjusted EBITDA	127,991	134,280	249,188	263,549
Operating Segments \| Performance Services
Segment Reporting Information [Line Items]
Non-GAAP Adjusted EBITDA	43,203	39,010	62,569	62,725
Corporate
Segment Reporting Information [Line Items]
Non-GAAP Adjusted EBITDA	$ (30,658)	$ (31,274)	$ (61,841)	$ (62,555)